Marquette University

e-Publications@Marquette
Dissertations (1934 -)

Dissertations, Theses, and Professional
Projects

Functional and Structural Studies of Cytochromes P450 by
Resonance Raman Spectroscopy
Yilin Liu
Marquette University

Follow this and additional works at: https://epublications.marquette.edu/dissertations_mu
Part of the Biological and Chemical Physics Commons, Organic Chemistry Commons, and the
Physical Chemistry Commons

Recommended Citation
Liu, Yilin, "Functional and Structural Studies of Cytochromes P450 by Resonance Raman Spectroscopy"
(2017). Dissertations (1934 -). 732.
https://epublications.marquette.edu/dissertations_mu/732

1
FUNCTIONAL AND STRUCTURAL STUDIES OF CYTOCHROMES P450 BY
RESONANCE RAMAN SPECTROSCOPY

By Yilin Liu, B.Sc.

A Dissertation submitted to Faculty of the Graduate School,
Marquette University,
in Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy

Milwaukee, Wisconsin
August 2017

i
ABSTRACT
FUNCTIONAL AND STRUCTURAL STUDIES OF CYTOCHROMES P450 BY
RESONANCE RAMAN SPECTROSCOPY
By Yilin Liu, B.Sc.
Marquette University
Cytochrome P450 is a broad class of heme monooxygenase enzymes which
catalyze various oxidative transformations. There are two main kinds of mammalian
P450s: steroidogenic and drug metabolizing P450s. The first project involves a
steroidogenic P450, CYP17A1, occupying a central role in the biosynthesis of steroid
hormones. It catalyzes hydroxylation reaction on pregnenolone and progesterone,
generating 17OH-pregnenolone and 17OH-progesterone, presumably utilizing a
“Compound I” species. However, these hydroxylated products can be further processed
in a second oxidative cycle to cleave the C17–C20 bond to form dehydroepiandrosterone
or androstenedione, respectively, a crucial step in androgen production. Interestingly, it is
well known that cytochrome b5 is a key regulator of androgen synthesis, by a mechanism
that is still not well understood. As the enzymes involved here are both membrane-bound,
resonance Raman (rR) studies are performed on unique nanodisc-based dyads to
investigate their interaction, including characterization of their ferric state and unstable
dioxygen intermediates, the essential results supporting an electron transfer role of cyt b5.
The second project is focused on a fusion enzyme called P450BM3, which possesses a
covalently linked cytochrome P450 reductase. This fusion enzyme is clearly a good target
for biotechnologically application. In the present work, rR studies focus on several
biotechnologically important mutants of P450BM3, which have altered substrate
selectivity, allowing metabolism of the human proton pump inhibitor, omeprazole,
producing metabolites that precisely match those generated by human CYP2C19, thereby
providing an inexpensive source of these precious materials that are needed for drug
metabolism studies. Specifically, it is shown that binding of omeprazole to these BM3
mutants leads to differing degrees of high spin state conversion of the heme iron.
Furthermore, the ferrous CO adduct were acquired to interrogate the effect of substrate
binding on the distal pocket architecture. The third project involves the
biotechnologically important peroxygenases. Specifically, rR studies are applied to
CYP152L1 and CYP152L2 enzymes, which are able to convert fatty acids into
industrially valuable terminal alkenes without requiring a complex reductase system.
Herein, using chemical strategies to trap and isolate key reaction intermediates, rR
spectroscopy is being employed to probe their structure and reactivity.
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Chapter 1: General Introduction

1.1 Introduction of heme proteins

Heme enzymes are one of the most important classes of proteins that perform a
variety of functions throughout the biosphegxre, such as oxygen storage and transfer,
electron transfer and catalyzing difficult chemical reactions such as hydroxylation of
organic substrates. One or more heme cofactors1 are recruited into enzyme active sites to
accomplish these diverse functions.
Iron-porphyrin complex, known as heme cofactor, plays a key role in biological
process and metabolic pathways. So far, several different types of natural heme prosthetic
groups are identified, such as heme a, heme b, heme c, heme d, and siroheme.2 While
among these groups, b type heme is the most abundant and widely encountered. The
molecular structure is shown in Figure 1.1.1, four methyl groups are located at the 1-, 3-,
5-, and 8- position, two vinly groups are at the 2-, 4- position and two propionate groups
are at the 6-, 7- positions. The upper side of porphyrin is hydrophobic which usually
interact with the hydrophobic amino acid residues, while the lower side is more polar
with the propionate groups attached, preferring to interact with the polar amino acids
residues, such as glutamate and aspartate. Thus, heme b is bound in the heme pocket via
the non-covalent interactions with amino acid residues as well as by establishing
coordination between heme iron and an endogenous axial ligand, such as histidine in
myoglobin; relevant to this work, the axial ligand is cysteine in cytochrome P450.3

2
The functions of heme b type proteins are various. Hemoglobin is the most
common O2 transport protein in nature and myoglobin is the O2 storage sites in muscle
cells,4 cytochrome b5 is known to be involved in the electron transfer of oxidation
reactions in biological tissues,5 some heme-based sensor proteins such as FixL,6 CooA,7
and sGC,8 are functioned to sense O2, CO and NO molecules to initiate some chemistry
requirement in biological system, and cytochrome P450 and some peroxidases are used to
oxidize a wide range of substrates by employing O2 and H2O2, respectively.9 Thus, study
of these enzyme structures and catalytic mechanisms becomes very significant.
Resonance Raman spectroscopy is one of the most effective techniques to probe iron
electronic structure, heme peripheral environment, ligand binding properties as well as
characterization of intermediates in catalytic cycles.10

Figure 1.1.1 Molecular structure of heme b.
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1.1.1 Globins

The globins are an extensive family of proteins which all have very similar
structures, are commonly a three-dimensional folding of a few  helices to form a globin
fold which protects the bound heme group and allowing the oxygen binding and
transport.11 Myoglobin and hemoglobin are two main classes which are most well
studied. They are the first proteins for which crystal structures were determined by X-ray
crystallography.12 Myoglobin is very abundant in muscles in varieties of organisms,
serving as oxygen storage. It is a single peptide chain containing 153 amino acids, which
consists of eight helices connected by turns, with one bound heme (Figure 1.1.2).13
While hemoglobin carries oxygen from the lungs to peripheral tissues and returns carbon
dioxide back to lungs, it is a much larger protein than myoglobin, being a tetramer
consisting of two  chains and two  chains. It contains four heme prosthetic groups,
each one associated with one polypeptide chain (Figure 1.1.3).14 Both myoglobin and
hemoglobin bind oxygen at the iron atom in heme. In the deoxy form, ferrous heme iron
is coordinated by the imidazole part of histidine in proximal side (the fifth ligand), while
the sixth ligand is unoccupied, this position serving for binding oxygen. When oxygen
binds, the electronic structure of iron ion is rearranged, which gives the bright red color
of oxygen-rich blood.

4

Figure 1.1.2 A ribbon diagram of the sperm whale Myoglobin. Eight  helices are
labeled A through H and heme group were shown in ball and sticks.13

Figure 1.1.3 Quaternary structure of hemoglobin. (A) Ribbon diagram (B) A space
filling model.14

Though these two proteins adopt nearly identical structure for oxygen binding,
hemoglobin obviously has a much higher efficiency. Instead of exhibiting a simple
hyperbolic curve like myoglobin, it exhibits a distinct sigmoid curve which means it
binds oxygen cooperatively (Figure 1.1.4). This interesting process initiates from the
binding of one or two molecules of oxygen, which results in a structural change of the
whole protein, enhancing the oxygen affinity in the unligated subunits. Because of this
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allosteric effect, hemoglobin is more effective in transporting oxygen concentration in
lungs and tissues, loading up with oxygen in the oxygen-rich lungs and more effectively
release oxygen in the oxygen-poor tissues, where the reverse allosteric effect to this place
after one or two molecules of oxygen were dissociated.15

Figure 1.1.4 Oxygen binding by myoglobin (blue curve) and hemoglobin (green “S”
shape curve).15

1.1.2 Electron transfer hemeproteins

Redox reactions occur in many biological processes, such as photosynthesis and
respiration, which are two necessary processes that maintain life. Nature recruited
transition metals to overcome the kinetic barrier of these reactions. Cytochrome c and
cytochrome b5 are two representative proteins involved in a large number of biological
electron transfer process.16
Cytochrome c is an essential component in electron transport chain which is
found in inner membrane of mitochondria, where it participates in oxidation and
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reduction reactions to produce the energy currency, ATP. It is a small protein containing
around 100-120 amino acids with only 12kDa molecular weight.17 As shown in Figure
1.1.5, there are different types of heme found in cytochromes and cytochrome c contains
the c-type heme, with the axial ligands of histidine and methionine to covalently link to
the protein peptide chain. Another electron transport hemeprotein, cytochrome b5,
contains a bis-histidine ligated b-type heme and is found in bacteria, plants and animals.
They are membrane bound in mitochondria and microsome, while soluble in bacteria.
They can exhibit the redox potential span of ~400 mV and interact with their redox
partners primarily by electrostatic forces. Of interest in this study, cytochrome b5 is
involved in a fast input of the second electron to P450 monooxygenase enzyme, which is
critical for the oxygen activation.5

Figure 1.1.5 Schematic of various types of heme.18
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1.1.3 Signaling hemeproteins

There is a minor class of hemeproteins called sensor proteins, which can sense the
presence of small diatomic ligands such as oxygen, carbon monoxide and nitric oxide,
thereby responding to fluctuations in the levels, serving to regulate physiological
functions, adapting the changes in varieties of organism. All these proteins are composed
of a heme-containing domain and a coupled transmitter. Upon the binding of the diatomic
small molecules, the conformational of heme binding domain is transmitted to its coupled
functional domain (neighbored transmitter region) where it can modulates the signal
transduction to fulfil its physiological role.
Some well characterized signaling proteins are the bacterial O2 sensor, FixL,19 the
CO sensor, CooA20 and the NO sensors HNOX21 and soluble guanylate cyclase (sGC).
Taking the NO sensor sGC for an example, sGC is a heterodimeric enzyme (one 
subunit and one heme-containing  subunit), which contains a five-coordinated b-type
heme with the heme proximal coordination being provided by the protein amino acid
sidechain of a histidine residue in its nature ferrous form.22 Resonance Raman studies
have shown that this Fe-Nhis bond is the weakest in all hemeproteins, having a very low
frequency of iron histidine stretching mode (204 cm-1).23 Upon binding of NO molecule
in distal pocket, the proximal iron histidine bond cleavage leads to the protein
conformational change which further increases the sGC activity in the catalytic domain,
converting GTP to intercellular messenger cGMP (Figure 1.1.6). Following Le Chatlier’s
principle, sGC can spontaneously release NO molecules when NO levels drops to a
clinical value, thereby down regulating cGMP.24
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Figure 1.1.6 sGC in the NO signaling pathway.25

The discovery of heme sensor proteins has been increasing rapidly, with insights
into this class of protein mechanism being developed by using varies of biophysical
methods and crystallography, providing a better understanding how these heme binding
domain in turn controls the signal transduction domains.

1.1.4 Catalytic hemeproteins (cytochromes and peroxidases)

There are several broad classes of hemeproteins which serve to catalyze oxidation
reactions, one of which is the Cytochromes P450, which use O2 and two electrons and
two protons to oxygenate relatively inert substrates, and the other is peroxidases,
monooxygnease known using H2O2 for substrate oxidation. As shown in Figure 1.1.7,
heme oxygenase use NAD(P)H –dependent reductase system and O2 bound intermediate
to produce the active oxidant called compound I. While the peroxidase can directly
interact with H2O2 to produce compound 0 which then rapidly converts to compound I.
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Avoiding any need for partner reductase in the H2O2 activation pathway is a big
advantage, thus attracting a huge potential interest for biotechnological purpose. Though
peroxidases can operate without electron donor protein, H2O2 is a major source of
reactive oxygen species via Fenton chemistry. Since the release of toxic hydroxyl radicals
is highly destructive to the enzyme active site, peroxidases facilitate heterolytic O-O
cleavage to avoid radical formation. Since Cytochrome P450s will be discussed later in a
much detail in the next sections, emphasis will be placed on the H2O2 driven peroxidases.

Figure 1.1.7 Oxygen and Hydrogen peroxide activation pathway.9

Peroxide enzymes use hydrogen peroxide to oxidize biological molecules
including a wide variety of substrates, playing multiple physiological roles, they have
been studied extensively owing to their ease of preparation of large amount of purified
enzymes. There are two well defined superfamilies of peroxidases: one belongs plant
peroxidase superfamily which contains enzymes from plant, fungal and bacteria, while
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the other superfamily is mammalian peroxidases such as lactoperoxidase and
prostaglandin H synthase. Among all different kinds of peroxidases, horseradish
peroxidase (HRP) was first to be thoroughly studied over the past century.
Horseradish peroxidase is an important heme-containing enzyme which exhibits
multiple physiological roles, including metabolism of 3-acetic acid, suberin formation
and cross-linking of cell wall polymers.26 It is a single polypeptide chain of 308 amino
acid residues, with a heme b cofactor bound via a histidine axial ligand. As shown in
Figure 1.1.8, there is a strong hydrogen bonding interaction between proximal histidine
170 and aspartic acid 247 residue, giving the axial ligand more imidazolate character,
lowering Fe3+/2+ redox potential. The distal pocket remains unoccupied by water and
ready for H2O2 turnover and substrate oxidation.

Figure 1.1.8 Horseradish peroxidase heme structure and key amino acids in the proximal
site.27
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Treatment of HRP with hydrogen peroxide yields a relatively stable compound I
species (i.e.; a porphyrin pi cation radical) with a distinct green color; then is formed by
removal of one electron from iron and a second from the porphyrin ring, with peroxide
being reduced to water. Then one electron oxidation of a substrate molecule, reduces the
porphyrin pi radical to generate compound II (a ferryl heme). Finally, compound II is
reduced to the ferric state by a one electron, one-proton transfer process. This whole
catalytic process is shown in Figure 1.1.9.

Figure 1.1.9 The reaction cycle of HRP (where AH2 and AH represent a reducing
substrate and its radical product); Roman numerals indicate iron oxidation state.28
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1.2 Cytochrome P450

1.2.1 General Introduction

Cytochromes P450 is one of the most remarkable enzyme families in the
biological kingdom, being found in diverse organisms, such as bacteria, yeast, plants,
fungi and mammals. Cytochrome P450 was first identified in liver microsome by
Kingenberg29 and Garfinkel30 in 1958. The name of P450 was given to it owing to the
fact that its carbon monoxide adduct exhibits a maximum Soret band at 450 nm, as shown
in Figure 1.2.1.

Figure 1.2.1 The absorption spectrum of cytochrome P450-CO complex.31
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So far over 18,000 P450 sequences have been discovered and this number keeps
increasing.32 The human genome encodes 57 cytochrome P450 proteins, while bacteria
possess 153 P450 families. In order to keep a record of this enormous information, a
nomenclature system has been derived based on the degree of protein sequencing
identity.33 CYP was abbreviated for cytochrome P450 followed by an Arabic number
representing a family in which the proteins have more than 40% sequence identity. Then
a letter, indicating the subfamily where proteins share more than 55 % same sequence
within the subfamily. Finally, an Arabic number at the end denotes the individual gene,
such as CYP2C8 (Figure 1.2.2). However, some cytochrome P450s are also named based
on its catalytic function and substrate name; for example, CYP5A1, thromboxane A2
synthase, was abbreviated to TXAS.34

Figure 1.2.2 Nomenclature basis for P450s and classification.

Cytochrome P450s are considered as a significant catalyst in biology, playing a
critical role in oxidizing a wide range of substrates.31 Although the reactions catalyzed by
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cytochrome P450 are extremely diverse, most of them can be accommodated to the basic
catalytic reaction below.

P450 can oxidize the organic substrate (RH) by employing the oxygen, to produce
a mono-oxygenated metabolite (ROH) and a molecule of water. In this reaction, two
electrons provided by redox proteins are required. Based on electron transport chain,
three main classes cytochrome P450s are described below. 35, 36.
Class I type cytochrome P450s usually are found in bacterial and some
mitochondrial P450s systems, both systems obtaining electrons from a pyridine
nucleotide (i.e. NADH or NADPH) via a FAD-containing reductase (FdR) and a Fe2S2
ferredoxin (Fdx). However, there is a main difference between bacteria and eukaryotes
systems. In bacteria, the reductase, ferredoxin and P450 are all soluble (Figure 1.2.3 A).
In eukaryotes, ferredoxin is alone soluble, while both the reductase and P450 are
membrane-associated proteins and can bound to the inner mitochondrial membrane, as
shown in Figure 1.2.3 B. Examples of Class I type P450 includes P450cam in bacteria.

Figure 1.2.3 Schematic organization of electron transfer in (A) Class I bacterial system
(B) Class I mitochondrial system.
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Class II type cytochrome P450s are involve in mostly microsomal P450 systems.
In this system, electrons are transported from NADPH to the heme of P450 via NADPHCytochrome P450 reductase (CPR) which contains two prosthetic groups, FAD (Flavin
adenine dinucleotide) and FMN (Flavin mononucleotide). Both NADPH-Cytochrome
P450 reductase and P450 are anchored in the membrane. The scheme of electron transfer
route is shown in Figure 1.2.4. In addition, a minor number of microsome P450s also use
cytochrome b5.

Figure 1.2.4 Schematic electron transfer route in P450s with NADPH-P450 reductase
system.37

Class III type P450s are self-sufficient and usually do not need any extra source of
electrons. Examples of this type includes P450 BM3, it consists of a single polypeptide
chain with two different domains, which the heme domain is fused to the reductase
domain containing an FAD and FMN. This novel type of fusion is defined as a new class
of discovered P450.
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1.2.2 Active site structure of Cytochrome P450

P450s are crucial in many biological processes, they are involved in breaking
down the xenobiotics in drug metabolism as well as in the biosynthesis of important
compounds such as steroids, lipids, and vitamins. In order to better understand the
structure-function relationship, very many studies have been undertaken to explore
structure function relationships. Owing to the difficulty with purification and
recombinant expression of membrane-bound P450s, the soluble P450s such as P450cam,
were most heavily studied at earlier time.
The P450 enzymes all are composed of a heme b bound through a thiolate axial
ligand to a single polypeptide chain consisting mainly of -helices and  sheets arranged
to form a globular protein, with a size of 40~55 kDa. Even though the complicated P450
enzymes have variable structures, the overall fold and topology are basically same.38 All
enzymes share a highly reserved core which consists of a four-helix bundle, three parallel
helices D, L, I and one antiparallel helix E, as shown in Figure 1.2.5. The long I helix
locates right above the heme prosthetic group and provides important amino acid residues
to interact with both substrate and molecular oxygen. While the L helix is located as the
proximal side of heme group to provide the cysteine residue to bind to the heme iron as
the fifth ligand. Various spectroscopic methods including Resonance Raman
spectroscopy was used to detect this iron-sulfur bond.39
Cytochrome P450 shows diverse conformation and marked regio- and stereoselectivity toward different substrates. The non-conserved region, is necessary for this
substrate binding and recognition.40 Six substrate recognition sites were identified by
Gotoh which constitute about 16% of the total residues, as shown in Figure 1.2.6. The
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SRS1 was assigned to the B’ helix region, parts of helices F and G and the F-G loop were
identified as SRS2 and SRS3. The center position of helix I was ruled as SRS4 which
contributes key role in substrate binding and reaction mechanism. The N-terminus of 4
was SRS5 and 2 connecting region which towards to active site in K helix was SRS6.
All these regions are quite flexible which allows the substrates entering and leaving the
heme pocket and catalyzing reactions subsequently.41

Figure 1.2.5 Schematic representation of P450cam structure.
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Figure 1.2.6 The substrate recognition sequence (SRS) regions in a ribbon
representation.42

1.2.3 Catalytic Mechanisms of Cytochrome P450

Owing to the diverse applications of cytochrome P450, there is a wide interest in
studying these various enzymes, especially the catalytic mechanism. An overall catalytic
cycle proposed is shown in Figure 1.2.7.43 In the resting state, the heme iron is in the six
coordinate, low-spin (6cLS) state, with a water molecule occupying the sixth ligand
position. Upon binding a substrate, water molecule was displaced from distal axial
position which bring heme iron from low spin state to a five coordinated high spin
(5cHS) state. Then an electron is passed from NADPH via a redox partner to the heme
iron, the ferric iron being reduced to the ferrous iron while still in high-spin state.
Molecular oxygen binds to the heme iron leading to an oxy-P450 species, which is more
properly formulated as a ferric superoxide species. Then a second electron is transferred
to the Fe-O-O fragment, forming a ferric peroxo species. Generally, this is followed by a
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fast protonation from surrounding amino acid residues or water molecule, to become a
ferric hydroperoxo species. A second protonation at the distal oxygen atom leads O-O
bond cleavage, with a water molecule leaving and formation of highly reactive species
compound I. This species hydroxylates the substrate and returns to the resting state after
product release.
However, three major abortive reactions can happen in this cycle.44 The oxyferrous enzyme can be auto-oxidized back to its resting state with leaving of a superoxide
ion. In addition to this auto-oxidation process, a so-called “peroxide shunt” pathway is
possible by producing H2O2 from hydroperoxide. The last abortive reaction is “oxidase
shunt”, the compound I can return to the resting state by leaving two molecules water
without going to oxygenate the substrate. These uncoupling processes may happen when
the electron or proton delivery is not timely, or the substrate is positioned inappropriately.

Figure 1.2.7. Catalytic cycle of P450.45
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1.2.3.1 Substrate binding

The hydrophobic substrate binds in pocket above heme cofactor and the water
molecule is displaced. This process not only shifts the heme iron from low spin to high
spin state, but also raises the redox potential from -300 mV to a 100mV more positive,
such as the case of camphor binding to P450cam.46 The redox potential shift guarantees
electrons are only transferred to the enzyme in substrate-bound form; i.e., since the
midpoint potential of reducing equivalent (NADPH) is -320 mV, this balance ensures no
waste of NAD(P)H and avoids reducing equivalents formation of toxic species such as
superoxide. Moreover, conditions such as temperature, pH and solvent may also affect
the low spin and high spin equilibrium as well as the redox potential of heme iron.
Basically, the interactions of substrate with P450s can be seen in the spectral
properties of the enzyme. According to the observed UV spectral changes of P450 upon
binding substrates, P450s can be classified into three catalogues: type I and type II.47
Specifically, type I substrate can cause the heme iron change from 6cLS to the 5cHS
state, which can be seen from the UV-vis spectra that the decrease of an 420 nm band and
an increase at 390 nm depending on the percentage of high-spin state heme iron.
Compared with type I substrates, type II substrates usually are inhibitors or certain other
substrates which can directly ligate to the heme iron, forming tightly-bound complexes;
e.g., N atoms of aromatic and aliphatic amines. The spectrum generally shows a low spin
iron.

21
1.2.3.2 Oxygen complex

Oxygen can readily binds to reduced P450 in substrate bound form, forming the
oxy complex which is usually depicted as the ferric superoxide complex, as mentioned
above. The gross structure is very similar with the oxygen carrier such as hemoglobin and
myoglobin. According to the X-ray crystal structure of P450cam ferrous dioxygen
adduct, as shown in Figure 1.2.8, bimolecular oxygen binds to the heme iron in an end-on
form with the angle of Fe-O-O 132°, the distance between iron and the nearest O atom is
1.8Å. The iron is slightly out of plane while the heme becomes flatter. The Asp251 and
Thr252 residues play critical roles, serving as H-bond donor and proton transfer agents.48

Figure 1.2.8 Stereoview of the camphor complex of ferrous dioxygen-bound P450cam.
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1.2.3.3 Peroxo and Hydroperoxo intermediate

With the second electron transferred to the heme iron, the ferric superoxide
species is reduced to the ferric peroxide complex in the catalytic cycle. This species is
quickly protonated to form a hydroperoxo intermediate. Both of these two intermediates
are in low spin state. Owing to rapid delivery of a second proton and facile O-O bond
cleavage to generate compound I, isolation and stabilization of these is extremely
difficult. As will be seen, cryogenic radiolysis is one of the methods that can be used to
trap those intermediates. It was demonstrated that the peroxo species was stable enough
to be characterized in the frozen solution at 77K, and thus the hydroperoxo intermediate
could be obtained by annealing to elevated temperature.49 By using this method, both
intermediates were identified by spectroscopic methods such as UV-vis, EPR and
resonance Raman spectroscopy.50
1.2.3.4 Compound I

The protonation of ferric hydroperoxo species and the heterolytic cleavage of the
O-O bond lead to the formation of Compound I and release of a molecule of water.
Compound I has been characterized as an iron (IV) oxo species, with a π cation radical
located on the porphyrin macrocycle. In the presence of substrate, compound I rapidly
reacts and is difficult to capture. Over the past decades, different models and methods
were tried to characterize compound I with limited success.51 However, recently
compound I was captured and detected in CYP119 by reacting with m-chloroperbenzoic
acid, thus enable spectroscopic methods to characterize it. As expected, Mossbauer and
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EPR spectra indicated compound I is a Fe (IV) =O species with the ferry iron spin (S=1)
antiferromagnetically, porphyrin radical spin equals ½ to yield the total spin state ½.52
1.2.3.5 Hydroxylation of substrate

Hydroxylation of substrate is the last step in the catalytic cycle, where Compound
I inserts an O atom into the hydrophobic substrate and returns back to the resting state by
releasing the product. It is generally accepted that the mechanism for substrate
hydroxylation is a radical rebound process.53 Compound I abstracts a hydrogen atom
from the substrate while leaving a carbon radical, and this radical can rebound to the
species with a recombination process to give the hydroxylation product.

1.3 Resonance Raman Spectroscopy

1.3.1 The Raman Effect

Resonance Raman spectroscopy is a powerful method to probe the active site
structure of heme proteins and other metalloproteins because the vibrational frequencies
and intensities are very sensitive to the structure and the protein environment. Although
both IR and Raman spectroscopy can be employed to investigate molecular vibration
modes, Raman is best to be used in the symmetric and polar molecules. In addition, IR
has difficulty working with aqueous solution owing to the intense absorption of H2O
throughout the IR region which make the measurement inconvenient since most proteins
are measured in aqueous solution. However, Raman spectroscopy does not suffer this

24
limitation because water is a poor Raman scatterer.10 The mechanism for Raman
spectroscopy can be explained via the energy level scheme as shown in Figure 1.3.1.
When a monochromatic light from a laser source with frequency impinges on the
sample, it can interact with molecules and lead to the laser energies either unchanged or
being shifted up or down. In general, most of light will be scattered as the same energy
with the incident light, which is called Rayleigh scattering, giving a very intense peak in
the spectrum.
However, some of the incident light is scattered at lower energy if the molecule
undergoes a transition from the ground vibrational state (0) to an excited vibrational
state (1), which is referred as Stokes Raman Scattering. Occasionally a photon
encounters a molecule that is vibrational excited (e.g., in the 1 state) and the scattering
process leaves the molecule in 0, i.e., free photon gains energy from the molecule. This
is called anti-Stokes scattering. The intensities of Stokes scattering is stronger than the
anti-Stokes region, because few molecules will occupy an excited vibrational state,
according to the Maxwell-Bolziman distribution law. The line thickness is roughly
proportional to the intensity strength from different scattering in Figure 1.3.1. Thus, the
scattering intensities of Strokes line is reported as a function of frequencies in Raman
spectroscopy.
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Figure 1.3.1 Energy level scheme of vibrational Raman scattering process.

Resonance Raman spectroscopy can selectively enhance the vibrational modes by
using the laser excitation line which is close to the electronic absorption of the
chromophoric heme prosthetic group, which is necessary for biological macromolecules
which contain thousands of atoms and vibrational frequencies. A detailed illustration of
enhanced resonance Raman spectroscopy is shown in Figure 1.3.2, trace A exhibits the
structure of a complicated molecule tris-phenanthroline Fe (II) and trace B shows the
corresponding absorption spectra with a strong MLCT transition appearing at 514.5 nm.
As seen in trace C, different excitation laser lines were employed to characterize the
samples which contain a non-enhanced internal standard (SO42-). When the 647.1nm
excitation line is used (far from the MLCT maximum), the Raman spectra is dominated
by the sulfate ion with (S-O) occurring at 981 cm-1. However, as the excitation line
approaches to the MLCT maximum bands, the vibrational modes for tris-phenanthroline
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Fe (II) are greatly enhanced, even though its concentration is 1000 times less than the
internal standard sulfate ion.54

Figure 1.3.2 (A) Structure of tris-phenanthroline Fe(II); (B) Absorption spectroscopy of
tris-phenanthroline Fe(II); (C) Resonance Raman spectroscopy with different excitation
laser lines.

1.3.2 Resonance Raman Spectroscopy applied in heme proteins

Resonance Raman spectroscopy is a powerful method to study the structure and
function of metalloproteins especially heme enzymes. By adjusting the wavelength of the
exciting laser line close to that of allowed electronic transition in a molecule, certain
vibrational modes can be selectively enhanced. Such an advantage provides the
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possibility to collect good quality data even though using a small amount of sample. For
example, hemoglobin is a large molecule with a molecular weight of 64 kDa, and its
visible spectra is shown in Figure 1.3.3.55 Generally, the vibrational modes of the peptide
chain gains much weaker scattering and are not detectable, however, if a deep UV laser is
applied, at 280 nm, it will selectively enhance vibrational modes from the surrounding
amino acid residues in hemoglobin such as tyrosine, histidine, tryptophan and
phenylalanine, which have electronic absorption in this region.56 Alternatively, if the
laser line is near the Soret band (most intense π-π* transition), only the heme bands can
be seen. Thus resonance Raman spectroscopy allows us to observe the vibrational modes
only in the active site.

Figure 1.3.3 Electronic absorption spectroscopy of human hemoglobin.
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1.4 Resonance Raman studies of Iron-axial ligated P450 Adducts

1.4.1 Metal-ligand interactions in Hemeproteins

The heme prosthetic group in heme enzymes is capable of binding the
exogenouos diatomic ligands XY, such as CO, NO and O2. The Fe-XY adduct can
interact with the surrounding amino acid residues, affecting the bond strength of the Fe-X
and X-Y linkage, as reflected in changes of the vibrational modes by resonance Raman
spectroscopy. Binding the exogenous ligands can activate or inhibit key biological
processes. For example, hemoglobin can transport O2 by ligation of molecular oxygen
with heme iron, whereas binding with CO can prevent O2 binding. The general geometry
of Fe-X-Y can be linear or bent depending on the electronic configurations and bond
properties of XY ligands. As shown in Table 1.4.1, The CO ligand has an empty π*
orbitals and thus form a linear adduct which dπ- π* overlaps in a perpendicular directions.
However, NO and O2 have one and two electrons on π* orbitals, respectively, and thus
form the bent geometry, owing to a π antibonding interactions. However, the geometry
can be disturbed by the steric hindrance in the protein environment.57
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Table 1.4.1. Electronic configuration and bond properties of diatomic ligands.

The binding interactions between iron and the ligand can be classified into two
kinds; σ-bonding and π-bonding, as shown in Figure 1.4.1. σ-bonding is formed by the
interaction between the metal dz2 with either the ligand lone pair electrons or the π*
orbital of ligand. Because the energies of the dz2 and π* orbitals are very close, the
strength of bond is relatively strong. In the case of CO, NO and O2, the energy of π*
orbitals decrease from CO to NO to O2, leading to increased bond strength.
The π-bonding is formed between the metal dπ (dxz and dyz orbitals) and the ligand
π* orbital. This interaction involves the electron shift from iron to the ligand in the dπ- π*
system and a back donation to the iron in the σ system, thus leading to a strengthened MX bond and a weakened X-Y bond. In addition, the axial ligand of heme protein, usually
histidine or cysteine, can also affect these bond strengths. A σ competition between the
trans axial ligand and the exogenous ligand can weaken the Fe-X bond.
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Figure 1.4.1 Representation of σ- and π-bonding interactions between metal ion and
diatomic ligand.58
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1.4.2 Resonance Raman spectroscopy to probe CO, NO and O2 P450 complex and
unstable fleeting intermediates in the catalytic cycle.

1.4.2.1 Ferrous CO P450 complex

CO can bind to the high spin ferrous heme iron to produce a low spin heme in
P450s, giving a maximal absorption band around 450 nm. As mentioned earlier, the FeCO fragment is expected to be linear. However, in some cases, it can cause a slight bent
geometry due to the steric constriction in the protein environment.
Since resonance Raman is an effective method to detect the subtle environmental
alternations, vibrational modes of Fe-CO fragment have been identified by isotopic
substitution of the bound CO. Both the modes of Fe-C and C-O can be enhanced in
resonance with the heme Soret absorption band, i.e, using the 441.6 nm excitation line.
In Figure 1.4.2, it can be seen that a band occurs at 481 cm-1 shifted to 478 cm-1
upon the isotope substitution from 12C18O to 13C16O in substrate-free P450cam, and upon
substitution by 13C16O, it shifted to 473 cm-1. Thus this feature occurs at 481 cm-1 was
first assigned as (Fe-CO) stretching mode.59
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Figure 1.4.2. Effect of the substitution by isotope-labeled CO on the substrate-free form
of P450cam.

The Fe-C-O bending vibration was assigned at 558 cm-1 owing to the significant
shift (14 cm-1) upon 13C16O substitution, giving only a -3 cm-1 on 12C18O substitution. The
substrate binding on the P450cam caused a shift of Fe-CO stretching mode from 481cm-1
to 464 cm-1, which indicates the bound substrate can interact with Fe-CO fragment,
distorting the active site structure.
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1.4.2.2 NO P450 complex

Nitric Oxide is able to bind with heme iron both in ferric and ferrous states. The
geometry of Fe (III)NO is expected to be linear for compounds without distal steric
effects, whereas it can become slight bent in the presence of substrates, in a manner
similar to Fe (II)CO since they are isoelectronic. However, one main difference between
these two adducts is that the electron in the NO π* orbital is delocalized over the Fe dπ
and NO π* orbitals which lead to a strengthened NO bond owing to an increased bond
order. This can also be detected in the high frequency region of rR spectra, where a
feature occuring at 1877 cm-1 assigned as  (NO) was observed.60 Limited studies have
been conducted on Fe(III)NO, owing to laser-induced photo reactivity and O2 sensitivity.
Resonance Raman spectra of the nitric oxide adducts of ferrous cytochrome
P450cam in substrate-free form and different substrate-bound forms were reported by Hu
et.al.61 By using isotopic substations of 15N and 18O, the axial vibrations were assigned.
The  (Fe-NO) stretching mode and Fe-NO) bending mode are assigned at 522 and
546 cm-1, respectively. The geometry of Fe(II)NO fragment is expected to be inherently
bent, but can also be sensitive to the presence of different substrates. Thus, it is
interesting to investigate the bending modes of Fe-N-O for various substrates. It is shown
that the size of substrate can affect these modes, the larger substrate binding can lead to
an enhancement of the Fe-N-O bending mode.
1.4.2.3 Fe-dioxygen complex

The study of P450-O2 adducts is a way to get direct information about the
catalytic mechanism. However, there are lots of challenges to acquire the vibrational data
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for the dioxygen adduct, owing to its instability; it can be easily autoxidized back to Fe
(III) OH rapidly. In addition, for some heme proteins, it is difficult to detect the stretching
mode of O-O bond since it is only weak enhanced in the rR spectroscopy. However, in
the case of P450cam and selected proteins, it is found that the  (O-O) mode can be
enhanced owing to the fact that axial ligand is thiolate, the enhancement is presumably
attributable to altered electronic coupling involving the S-Fe-(O2-) fragment.62
The rR assignment of P450 dioxygen adducts was done by employing isotopic
labelling.62-63 In the case of camphor bound P450cam, the  (O-O) and  (Fe-O2)
stretching modes were assigned at 1140 cm-1 and 540 cm-1 by using 18O substitution,
respectively. Both of these two modes are sensitive to the substrate size; when the
camphor is replaced with the larger sized substrate, adamantanone, two  (O-O) modes
can be seen at 1139 and 1147 cm -1, indicating that in the presence of adamantanone, two
structural conformer exist.64
1.4.2.4 Cryoradiolysis studies on intermediates in hemeprotein catalytic cycle

Resonance Raman spectroscopy is not only used to characterize the oxy complex,
but also can be applied to following fleeting intermediates in the catalytic cycle including
peroxo-, hydroperoxo- ferric forms. Radiolytic reduction in frozen solutions is an
effective method for trapping and studying the unstable catalytic intermediates in P450s.
Usually, radiolysis of a protein solution can produce lot of radicals which can lead to
diverse products depending on the solvent condition; however, using a frozen solution,
one can avoid such obstacles because the diffusion in solid matrix is limited.65 Thus, the
cryoradiolysis studies on frozen samples made accumulating the active intermediates
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possible. The irradiation on hemeprotein frozen solution can be conducted at 77K and
irradiated by  ray which is usually a 60Co source to generate the free electrons in
presence of some organic solvent such as glycerol and ethylene glycol. This method was
first pioneered by Martyn Symons in 1980s,66 and more recently defined and used
extensively by Hoffman and Sligar and coworkers.67
The general process of cryoradiolysis of hemeproteins is shown in Figure 1.4.3.
The hemeprotein is prepared in H2O or D2O buffer which both containing around 30%
glycerol which is a good electron source during irradiation. By adding the chemical
reductant such as sodium dithionite in anaerobic environment, the ferric iron can be
reduced to ferrous state, then the dioxygen gas is bubbled into the protein solution at low
temperature and quickly frozen in liquid nitrogen. Such trapped dioxygen adduct (Figure
1.4.3 a) can be characterized by resonance Raman spectroscopy. Upon the -ray
irradiation on the frozen solution, the electrons and free radicals were produced and the
electrons can migrate to the Fe-O-O fragment, at this temperature, only electrons can
move but the proton and other species are restricted. At this point, the ferric peroxo
species (Figure 1.4.3 b) can be generated and characterized. For the next stage, to allow
the proton transfer to generate the hydroperoxo form (Figure 1.4.3 c), the samples need to
be carefully annealed at higher temperature, the precise temperature could be detected by
EPR. Ideally, subsequent annealing further allows the transfer of another proton to
facilitate O-O bound cleavage to yield compound I (Figure 1.4.3 d) or eventually neutral
compound II species (Figure 1.4.3 e), but usually they are too reactive to trap.
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Figure 1.4.3 Process of cryoreduction of heme proteins.

1.5 Nanodiscs Technology application in Cytochrome P450

The self-assembled Nanodisc system is considered as a versatile tool to study
structure and function of membrane proteins by rendering them soluble in aqueous
solution while still providing them a native like bilayer environment to keep function
active.68 This system provides possibilities for measuring membrane-bound cytochrome
P450s which previously suffered limitation on using soluble P450s only. Moreover,
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assembly of membrane proteins is achieved by using this technique. It allows detailed
analysis from spectroscopic and kinetic methods which is extremely helpful to
understand the mechanism of P450’s catalytic cycle. So far, numerous membrane bound
P450s have been incorporated in nanodisc and characterized by rR spectroscopy. For
example, nanodisc incorporated CYP3A4 shows a fully spin-state conversion upon type-I
substrate binding.69 In addition, the nanodisc system is useful to isolate the unstable
catalytic intermediates in cryogenic methods.
Nanodiscs consist of an engineered scaffold protein that surrounding the lipid
domains which plays a key role in keeping protein homogenous and soluble, Figure 1.5.1
shows a schematic view of a nanodiscs. To approach this, the target membrane protein is
solubilized in detergent with phospholipids and scaffold protein. By adding hydrophobic
Bio Beads, the target protein self-assembles into a lipid bilayer discoid, the size being
dependent on the length of scaffold protein. The advantage of nanodisc, such as small
size, less light scattering and faster diffusion, allows careful characterizations of P450
enzymes in a native like environment.

Figure 1.5.1 Schematic view of a nanodisc.
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It is also possible to incorporate the target P450 with a reductase in one nanodisc,
which better mimic the interaction in membrane environment.70 One successful case is
the generation of cytochrome P450 reductase (CPR) and CYP3A4 in the same nanodiscs
(Figure 1.5.2). Thus, starting with solubilizing both proteins in detergent, once the Bio
Beads are removed, nanodiscs can be assembled in different ways. There are several
possibilities that different types of nanodiscs are generated; it could be the empty
nanodiscs, nanodiscs with single protein incorporated (either CPR or CYP3A4), or both
properly incorporated. Desired products can be separated by using several different
columns, e.g., firstly, a size exclusion column is applied to the mixture to obtain the
nanodiscs with right size (some get proteins incorporated and some are empty), then the
fractions are applied on a Nickel affinity column, which can selectively bind the CYP3A4
incorporated nanodiscs, then the eluted fractions are loaded into a 2’ 5’ ADP column
which allows binding of CPR incorporated nanodics, finally, both CYP3A4 and CPR
incorporated nanodicscs products can be washed out from this column. This is amazing
because it is able to study a protein with the reductase partner in isolated membrane. You
can never study those in aqueous solution because different kinds of aggregate.
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Figure 1.5.2 Process of the self-assembly of CYP3A4 and CPR into Nanodiscs.70

However, this approach requires generating a large excess of proteins
incorporated in nanodiscs, with low overall yield. So recently, a new alternative approach
was described by Dr. Sligar’s group, by directly incorporating of CPR into a performed
population of CYP3A4 nanodiscs, a stable and fully functional complex could formed
within several minutes at 37 Celsius degree.71 The optimized ratio between CPR:
CYP3A4 is found to be 2:1, when the ratio is 1:1, only 40% of 3A4 nanodisc was
incorporated with reductase, but when at 2:1 ratio, most of CYP3A4 is involved in the
1:1 complex. If the ratio increase further, a larger complexes with an increasing amount
of CPR per CYP3A4 are formed. A highly active nanodiscs form with both target protein
and reductase can be formed with high yield. Once formed, rR spectroscopy was used to
investigate different P450 enzyme either expressed from bacteria or the Nanodiscs
incorporated mammalian P450. In our studies, to better understand the interaction
between different proteins and heme environment, individual proteins such as CYP17A1
is investigated using rR spectroscopy.
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1.6 Overview of my research

Generally, the main goal of my research is to use resonance Raman spectroscopy
to study the structure and function of cytochromes P450. In our paper, the interaction
between CYP17A1 and its redox partner cytochrome b5 was undertaken, including
characterization of their ferric state and unstable intermediates, CYP17A1 ferrous
dioxygen adduct in presence of cyt b5. The second project is focused on the enzymes
which are good targets of exploration for biotechnologically useful purposes. There is
high interest in study of the enzyme called P450 BM3 with the fact that it is covalently
linked with its cytochrome P450 reductase, showing remarkably high monooxygenase
catalytic activity, can functional convert fatty acid to short chain hydrocarbons or other
commercial products. These rR studies are focus on several gatekeeper mutants of P450
BM3 which can alter substrates binding to allow the PPI drug, omeprazole, to be
processed. Specifically, the ferrous CO adduct are being analyzed to interrogate the effect
of substrate binding on the distal pocket architecture. In another project, trapping and
characterization of crucial intermediates in peroxygenases (CYP152L1 and CYP152L2)
by rR is performed, providing information about Compound I and Compound II
intermediates that can directly react with substrate. Aside from those important studies, it
is also of great interest to document any differences in the key Fe-O-O fragment of the
“precursor” to the Compound I intermediate. In addition, a small project dealing with the
enzyme, DGCR8, included as an appendix, the results having been recently published in
the ACS Journal of Biochemistry.72
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Chapter 2: Methods and material

2.1 Expression and purification of P450cam

The procedure for expression and purification of P450cam is summarized in this
section, just for practice and to get familiar with the purification process, making
preparation for collecting good quality rR data in later research work.
2.1.1 Agents and buffer

Trizma-HCl, Trizma base, potassium chloride, (R)-(+) camphor, potassium
monophosphate, potassium phosphate dibasic, ammonia sulfate, sodium chloride, bacto
tryptone, bacto yeast, LB broth, ampicillin, and antipain were purchased from SigmaAldrich. Pepstatin, DNase, RNase, lysozyme, Phenylmethylsulfonylflouride (PMSF) and
Isopropyl β-D-1-thiogalactopyranoside (IPTG) were obtained from Amresco. Leupeptin,
antipain, and amino levulinic acid (-ALA) were purchased from Alfa Aesar. The
DEAE-52 (pre-swollen) anion exchange was purchased from Whatman, Phenyl
Sepharose hydrophobic gel was obtained from GE Healthcare.
All buffers were made with highly deionized water (>16.5 MΩ/ cm) which is
generated by a deionizing system from Barnstead. The running buffer for DEAE column
contained 50 mM Tris-Cl, 25 mM KCl and 1 mM camphor, pH was adjusted to 7.5.
While the elution buffer for DEAE column was same as the running buffer except
increasing the KCl concentration to 300 mM. For phenyl sepharose column, the running
buffer contained 50mM Tris-Cl, 50 mM KCl, 25% (NH4)2SO4 and 1 mM camphor, pH
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was adjusted to 7.5. While the elution buffer was same as the running buffer but without
adding ammonia sulfate. Potassium phosphate buffer were made by adding K2HPO4
solution to KH2PO4 solution to bring up pH to 7.5. All buffers finally used contained
1mM camphor. To avoid the formation of inactive form P420, all the procedures were
done at 4°C environment.
2.1.2 The enzyme assay and purity index

The concentration of P450cam was determined by using the reported extinction
coefficients of their character absorption band. In this case, the camphor-bounded
P450cam has a 102 Mm-1 cm-1 coefficient at = 391 nm.73 According to beer’s law,
concentration would be easily obtained.
The UV absorbance ratio (A392/A280) was adopted to check the purity of the P450
protein. In the substrate-bound P450cam, an Rz (A392/A280) value of an enzyme greater
than 1.5 was shown as electrophoretically homogeneous.
2.1.3 Expression of P450cam

2.1.3.1 Preparation of LB agar Plates

1.75g LB agar was dissolved in 50ml distilled water in a plastic conical flask,
solution was heated in a microwave oven for 2 mints but pause every 15 seconds, gently
shaking to avoid formation of bubbles. Allow the solution to cool down to room
temperature, 50ul of 100mg/mL ampicillin was added. In a sterile environment, the
solution was poured into plates continuously until the solution cover the plates, cool
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down for 30mins. Transfer the transformed cells to the plates and spread the cell using
autoclaved glass beads. Incubate the cells at 37° for overnight to allow cell growth.
2.1.3.2 Preparation of 2YT media

24g bacto tryptone, 15g bacto yeast and 7.5g NaCl were dissolved in 1.5L highly
polished water in a 2L plastic bottle, water is added first to prevent micro-fog, four of
such kind of 2L bottles were prepared. To anther 250ml plastic Erlenmeyer flask, 2.5g
LB broth was dissolved in 80ml distilled water. All these five flasks were covered with
aluminum foil and autoclaved for 20 minutes. Cool it to room temperature. 1.5ml of
ampicillin was added into each four 2L plastic bottle, and solutions are stored in the cold
room overnight.
100uL of 100mg/mL ampicillin was added to the small flask, 1 colony of
P450cam culture in plates grown previously was transferred into this flask. Incubate this
culture solution at 37°C in the shaker with speed of 250 rpm for overnight.
2.1.3.3 Bacterial growth

15ml of culture solution grown overnight was transferred to each large plastic
bottle, then incubate for 45 minutes at 37°C with rate of 250 rpm. The growth of the
cells were checked by measuring optical density (OD600) values using UV-Vis, spectra
were taken to monitor until OD600 was 0.6~0.8. Results obtained are shown in the table
below.
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Table 2.1.1 Changes of OD600 values with time of cell growth.
Time (mins)
0
40
80
120
150
170
180
Abs at
0.0082 0.0142 0.0609 0.155 0.268 0.5048 0.7977
600nm
1M Isopropyl β-D-1-thiogalactopyranoside (IPTG) was prepared by dissolving
2.38g of IPTG in 10 mL water in a large tube. IPTG was stored in cold room with
aluminum foil covered to avoid photo degradation.
1.5mL of 1M IPTG and 167uL of 45 mg/mL aminolevulinic acid were added into
each flask to induce protein expression. The addition of IPTG to cultures causes lacl
repressor displacement from DNA, simultaneously inducing expression of T7 RNA
polymerase from the chromosome. The best time to add IPTG was when the cell shows
logarithmic growth phase, then IPTG can perform better to induce transcription.
Aminolevulinic acid (ALA) worked as a precursor for heme synthesis, which is added to
enhance the production of P450. Then these solutions were incubate at 24°C at the speed
of 190 rpm for 21hrs.
0.2g camphor was added into each flask one hour before harvest and incubated for
another hour. Cells were harvested by centrifuging at 7000rpm for 10 minutes. Cells were
collected in a plastic tube and stored in the freezer at -80°C. Mass of wet cells is 53.65g.
2.1.3.4 Cell lysis

Cell lysis was done in a lysis buffer by using sonication. To make lysis buffer, 1
mM Phenylmethylsulfonylflouride (PMSF), 1 g/mL Leupeptin, 1 g/mL Antipain, 1
g/mL Pepstatin, 32 units/mL DNAase, 3 units/mL RNAse, 1 g/mL Lysozyme were
added into running buffer (50 mM Tris buffer, pH=7.4, 25 mM KCl, 1 mM camphor) to
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dissolve the cell wall to release the protein. Assume the density of cell is 1 g/mL, the
final lysis volume would be 3 times of cell volume, equals to 150 mL in this case. Note
this volume included both the wet cells and lysis buffer.
The cells were physically cracked into small pieces and transferred to a 50ml
plastic beaker, and then cells were sonicated for 5 times for each time 1 minute to allow
cooling down, using the power 3, 60% duty and timer on hold. In all this process, the
cells were kept on ice to avoid frothing. The crude P450 were obtained by centrifugation
for 90 minutes at speed of 7000 rpm, using rotor of code 03. The solution was
concentrated to 20ml by using concentration cell. Buffer exchange was done on protein
by adding DEAE running buffer before loading onto the DEAE anion exchange column.
2.1.4 Purification of crude P450cam

2.1.4.1 DEAE-52 Column
According to manufacturer’s recommendation, the size of column should be about
twice of cell lysis solution. Specifically, 100 g of pre-swollen DEAE-52 resin were
suspended in 0.5M Tris acid, pH was adjusted to 7.4 by adding Tris base. The
supernatant fine particles were decanted after settle down for 30 minutes, this step was
repeated for 3 times to remove all the fine particles in order to slow down the flow rate of
column. Then the gel was degassed in a suction flask with gentle mixing for 45 minutes,
decant the top layer with fine particles, and a 4×25 cm column was packed. The column
was washed with 1L of running buffer to ensure the equilibration. The crude P450 was
loaded onto the column and washed 4 column volumes of the running buffer. The protein
was eluted by using a salt gradient of 25 mM to 300 mM KCl with a flow rate of 2-3
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mL/min. Fractions was collected every 2.5 mL and UV-Vis spectroscopy was used to
check purity. The factions with Rz values >0.5 were combined and concentrated for 10
mL for further purification.
2.1.4.2 Phenyl Sepharose (Hi-Res) Column

Phenyl Sepharose is a hydrophobic interaction column, the fraction of
hydrophobic amino acid in the protein will bind to the resin in the presence of moderate
to high concentration of salt. According to manufacturer’s recommendation, a 2×20 cm
column for phenyl sepharose gel was prepared, and this column was equilibrated with 4
columns volumes of running buffer (50 mM Tris buffer, pH=7.5, 25% (NH4)2SO4, 50
mM KCl, 1 mM camphor). Ammonia sulfate was added slowly to the protein obtained
from the DEAE column to make it saturate, ensure the solution is clear without protein
precipitation, diluted with running buffer if precipitation happened. Then this ammonia
sulfate saturated P450cam is loaded onto the phenyl sepharose column at the rate of 1
mL/min. The column was washed with several column volumes of running buffer to
obtain purer protein. Elute protein with elution buffer using a salt gradient of 25% ~0%.
Fractions were collected every 3 mL and checked by UV-Vis spectroscopy. Fractions 211 with Rz value > 1.4 were pooled, shown in Table 2.1.2 below, potassium phosphate
buffer was used to exchange buffer to remove ammonia sulfate, and the protein was
eventually concentrated to 200 L, stored in -80°C freezer.
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Table 2.1.2 Rz values > 1.4 fractions collected from phenyl Sepharos column.
Fractions

A280

A392

Rz

2

1.1134

1.6259

1.461

5

1.4157

2.3335

1.648

8

1.7204

2.7559

1.601

11

1.5567

2.534

1.627

2.2 Purification of Glycerol for cryogenic studies

Cryogenic radiolysis reduction is an effective method to trap the peroxo-ferric and
hydroperoxo-ferric intermediates, which is very helpful for mechanistic studies of
Cytochrome P450. In order to stabilize these intermediates, data needs to be collected at
cryogenic temperature in aqueous glycerol glasses. On the other hand, to prevent samples
freezing at low temperature, glycerol is also necessary when making oxy samples, as
preparation of this intermediate requires efficient mixing with oxygen. However, the
commercial glycerol exhibits strong fluorescence background in rR spectrum due to the
impurity, thus purification of glycerol is an absolute necessary for rR studies, the
procedure is summarized in following sections.
A low temperature apparatus used in our lab is shown in Figure 2.2.1. A double
wall glass cell was used to keep the low temperature by continuously adding liquid
nitrogen. Spectra were acquired using 415 nm from Kr+ laser (Coherent Innova Model
100-K3) with a 180 back-scattering geometry, laser power is maintained at 20mW.
Glycerol is used as solvent to form transparent glasses at 77K, in order to remove the
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fluorescence impurities that may obscure the Raman bands, glycerol was purified by
treating with charcoal74 and later vacuum distillation.
2.2.1 Treatment of glycerol with active carbon

99.5% Spectrophotometric grade glycerol and activated charcoal were purchased
from Sigma-Aldrich. 27mL of glycerol was mixed with 0.34g activated charcoal and
heated under a nitrogen atmosphere at 70℃ for 4 hours.

Figure 2.2.1 Set up for low temperature rR measurement.75

2.2.2 Vacuum distillation of glycerol

In order to remove charcoal and further purification, vacuum distillation was
applied. The mixture obtained above was placed in a round bottom flask and then

49
connected to vacuum line. The mixture was degassed first and then the temperature was
increased by heating very slowly in an oil bath. The glycerol starts to distill off at about
155 °C. The first 1ml glycerol was discarded; the middle part (around 20ml) was
collected in a 25ml flask. Figure 2.2.2 shows the set up for vacuum distillation of
glycerol.

Figure 2.2.2 Set up used for vacuum distillation of glycerol

Another method was tried to remove the charcoal in glycerol. After glycerol
reacted with charcoal for 4 hrs, the mixture was cooled down; 0.2mM syringe filter was
then used to remove charcoal instead of vacuum distillation. Transparent glycerol was
collected. Resonance Raman spectroscopy was used to check the fluorescence
background of each sample, as shown in Figure 2.2.3, it was noticed that the vacuum
distillation is the best method to get purer glycerol.
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Figure 2.2.3 High-frequency resonance Raman spectra of glycerol from manufacturer
and the purified glycerol according to the procedure above. (Measured with 415nm
excitation line, 20mw power)

2.3 Resonance Raman Measurement

The Resonance Raman spectra were acquired using a Spex 1269 spectrometer
equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton Instruments, NJ).
The 406.7 nm and 413.1nm excitation lines from a Kr+ laser (Coherent Innova Sabre Ion
Laser) were used to measure the ferric P450 and oxy samples. While the 441.6nm
excitation line from a He-Cd laser (IK Series He−Cd laser, Kimmon Koha CO., Ltd.) was
used to probe the P450 ferrous-CO form. The laser power incident on ferric samples was
~10 mW, while the power used for ferrous-CO or ferrous-O2 samples are adjusted to ~1
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mW. Rayleigh scattering was removed from the Raman signal by using an appropriate
notch filter (Kaiser Optical). Owing to thermal effects arising from photon absorption and
local heating by the laser beam, the possibility of decomposition of the samples can be
enhanced. To overcome this problem, the samples were placed in a N2–driven spinning
NMR tube and the spectra were collected by using a 180° backscattering geometry with a
cylindrical lens.76 All spectra were calibrated with fenchone and data were processed
with Gram/32 AI Software. The accumulation time for the RR spectra depended on the
quality of protein. The basic set-up for resonance Raman instrument is shown in Figure
2.2.4.

Figure 2.2.4 Basic Resonance Raman instrument set-up.
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Chapter 3. Studies of the interaction between CYP17 with reductase partner

Portions of this chapter have appeared in the paper:
Duggal, R,; Liu, Y,; Michael, C. G.; Ilia, G, D.; Kincaid, J. R.; Stephen, S. G.; .,
“Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen
synthesis” Biochemical and Biophysical Research Communications, 2016, 477, 202-208

3.1 Introduction

Cytochrome P450 17A1 (CYP17A1) is an important drug target for castration
resistant prostate cancer. It is a bi-functional enzyme, catalyzing production of
glucocorticoid precursors by hydroxylation of pregnene-nucleus, and androgen
biosynthesis by a second C-C lyase step, at the expense of glucocorticoid production. It is
also known that Cytochrome b5 (cyt b5) is a key regulator of CYP17 reactivity and
androgen synthesis in vivo, but the mechanism for this effect has been the subject of
intense debate for decades. Although its essential role of cyt b5 in the fatty acid
biosynthetic pathways is well appreciated,77 early work with hepatic drug metabolizing
enzymes often yielded conflicting results. For instance, Sato and coworkers suggested
that the binding of cytochrome b5 (cyt b5) to cytochrome P450 elicited a structural change
in the enzyme which activated product turnover, either by increasing the inherent
catalytic rate or by inhibiting non-productive auto-oxidative shunt processes (As shown
in Figure 3.1.1).78 Alternatively, as cyt b5 contains a bisimidazole coordinated heme,
direct transfer of electrons from cyt b5 to P450 has been proposed.79 In this latter role, the
relatively high redox potential of cyt b5 (~0 mV versus Normal Hydrogen Electrode)80
suggests that electron transfer to ferric P450 (redox potential ~ 300 mV vs. NHE) is
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unfavorable. Hence it was suggested that the redox function of cyt b5 involved electron
transfer to the ferrous dioxygen intermediate which has a redox potential near 0 mV thus
providing the “second electron” in the normal monooxygenase stoichiometry.81 In an
attempt to differentiate between these two roles, Coon and co-workers reconstituted apocyt b5 with manganese protoporphyrin IX.82 They observed no reduced Mn-b5 in the
presence of cytochrome P450 reductase (CPR) and NADPH, whereas iron cyt b5 was
rapidly reduced. Hence Mn-b5 is incapable of any electron transfer to the P450. From
their experiments on various P450 reactions they concluded that cyt b5 effects depend on
the specific P450 in question, the substrate being examined, and molar ratio of CPR to
P450. This suggested that their observations could not be explained solely by a simple
electron transfer role and some effects may also be caused by possible conformational
changes caused by cyt b5 binding. While the role of cyt b5 in drug metabolism continues
to be explored, a more interesting and potentially critical function of cyt b5, is in human
steroid biosynthesis.
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Figure 3.1.1 Cytochrome P450 reaction cycle. Black arrows represent the path followed
for CYP17A1 mediated hydroxylation chemistry, while red arrows represent the
CYP17A1 mediated carbon-carbon scission reaction, the lyase chemistry. The first
reduction is indicated as being carried out by CPR, while the second electron can be
donated by either CPR or cytochrome b5.105

The synthesis of androgens, estrogens and corticosteroids involves multiple P450
catalyzed reactions. Cytochrome P450 17A1 (CYP17A1) is a key player in these
reactions, being responsible for catalyzing 17-hydroxylation of pregnenolone and
progesterone followed by C17-C20 bond scission in a separate lyase reaction to form
dehydroepiandrosterone (DHEA) and androstenedione (AD) respectively (shown in
Figure 3.2.2). The hydroxylation reactions occur throughout a person’s lifetime, and
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when a person approaches adrenarche, the hydroxylated products can be shunted towards
the subsequent step of formation of androgenic precursors by CYP17A1 in addition to the
production of glucocorticoids.83 The presence of membrane bound form of cyt b5 has
been known to selectively and significantly enhance the rate of the lyase reaction.84
Mutations of CYP17A1 surface residues: R347, R358 and K89 which are known to
interact with cyt b5, have been shown to cause impairment of lyase activity. In a recent
report, significant lyase impairment was shown in mice testicular Leydig cells lacking cyt
b5.85 Additionally, male patients with mutations causing a lack of cyt b5 present with
pseudo hermaphroditism, while high cyt b5 expression in adrenocortical adenomas in
Cushing’s syndrome patients has been associated with increased androgen synthesis.86
Clearly, cyt b5 has a physiological significance in maintaining normal levels of androgen
synthesis. The nature of this role has been long debated,84 87 88 89 with Auchus and
coworkers studying lyase activity in recombinant yeast using apo b5 which stimulated the
lyase reaction, leading these workers to conclude that there is no redox role.90 A similar
report from Akhtar and coworkers mentions unpublished results demonstrating lyase
enhancement in a reconstituted system utilizing Mn-b5. On the contrary, Estabrook and
others demonstrated in an in vitro reconstituted system in the presence of lipids that a
zinc substituted derivative of b5 did not stimulate the lyase activity of CYP17A1, and that
the previous reports of rate enhancement by apo b5 are the result of transfer of the heme
group from the P450 to apo b5 forming the holoenzyme.91 Another property of cyt b5 that
complicates all previous reports is the need for an intact membrane to influence the P450
activity.92 Given the key importance of cyt b5 in the regulation of androgen synthesis, it is
imperative that this disparity about the role of cyt b5 be solved in a reproducible system
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representative of the membrane environment of these proteins. To this end, we employ
the Nanodisc system to reconstitute CYP17A1, CPR and cyt b5 in controlled
stoichiometric ratios. We reconstituted cyt b5 with manganese protoporphyrin IX and
investigated the rate of lyase reaction by CYP17A1 in Nanodiscs, with iron containing
cyt b5, or with Mn-protoporphyrin IX substituted form of cyt b5 (Mn-b5) and compared
each case versus the rate in the absence of cyt b5. In humans, androgens are primarily
derived from the 17-hydroxypregnenolone substrate, therefore we decided to investigate
this reaction to determine whether cyt b5 is a redox donor in CYP17A1 mediated lyase
reaction for androgen synthesis. Additionally, we probed the ferric resting state of
CYP17A1 in the presence of native substrates to indicate formation of the b5-CYP17A1
complex.

x
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Figure 3.1.2 CYP17A1 catalyzed reactions in steroidogenesis.
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3.2 Experimental

3.2.1 Assemble CYP17 in nanodisc

The expression and purification of CYP17A1 was performed as described.93 The
expression and purification of membrane scaffold protein and cyt b5 were performed as
described.94 71 Both samples were prepared by our collaborator, Dr. Stephen Sligar’s
group. To assemble CYP17 in nanodiscs, materials such as membrane scaffold proteins,
phospholipids and bio beads need to be prepared ahead. Among which, membrane
scaffold proteins can be expressed and purified followed by a previous published
protocol.95 And Bio beads we used here is called amberlite XAD-2 which can be
purchased from Sigma Aldrich (catalog number is 21646-1). These polystyrene beads
need to be washed with ethanol in advance and thoroughly rinsed with water.
Phospholipid stock solutions are prepared in chloroform (50-100 mM, of
precisely known concentration). As shown in Figure 3.2.1, to prepare a thin film of the
proper amount of lipid, the desired precise amount of the chloroform solution of lipid was
dispensed into a glass tube. The chloroform was removed by using a gentle stream of
nitrogen gas to evaporate the chloroform; this was continued for ~ 4 hours in a fume
hood. To further remove the residual solvent, the tube was placed in a vacuum desiccator
under high vacuum overnight. Then a thin film should be seen on the wall of tube. Dried
lipid has an opaque, white appearance. Then adding triton 100 contained buffer and
vortex the tube, sonicate the solution in an ultrasonic bath until the solution is clear, and
no lipid remains on the walls of the tube. The working lipid stock for the assembly
mixture is ready. All these procedures result in a heterogeneous population of unilamellar
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vesicles whose final size distribution is very sensitive to slightly changes in experimental
conditions.

Figure 3.2.1 Preparation of working lipid stock.

To generate homogenous nanodiscs structure, the most key factor to success is
having the phospholipids, scaffold protein and target protein in correct stoichiometry. If
the stoichiometry ratio is not controlled strictly, then various other aggregates will form.
According to previous studies, the optimized ratio between POPC and MSP1 is 65:1 at 4
degree,96 as shown in the Table 3.2.1. To get the exact stoichiometry ratio, the
concentration of lipids and MSP needs to be determined carefully. MSP concentration is
determined spectrophotometrically using beer’s law using molar extinction coefficient
18200 @ 280nm. To successfully assemble CYP17 in Nanodiscs, Final reconstitution
molar ratio of mixture is 0.1:65:1 of CYP17A1/POPC/MSP1.

Table 3.2.1 Idea stoichiometry of membrane scaffold protein (MSP) and target protein at
different incubation temperature.

The concentration of lipid solution is determined by phosphate analysis.97 By
developing a calibration curve (Figure 3.2.2) of phosphate standard (Table 3.2.2), we can
easily calculate the concentration of stock solution, here is 98.5mM. In details, the
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solution was first heated in acidic medium to liberate the inorganic phosphate, reacting
with ammonium molybdate to form phosphomolybdic acid, this acid can form highly
colored molybdenum blue after reduction by ascorbic acid, which has strong absorption
at 820 nm.
1.2000

y = 0.00615x + 0.16345
R² = 0.99883

1.0000
0.8000
0.6000
0.4000
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0
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Figure 3.2.2 Calibration curve of a series of standards of phospholipids.

Table 3.2.2 Concentration of phospholipid standard prepared for calibration curve.
nmol P

uL standard

0

0

16.2

25

32.5

50

48.8

75

65

100

81.2

125

97.5

150

113.8

175

130

200

162.5

250
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Once we set up the reconstitution mixture in an ideal stoichiometry, the Bio Beads
are removed to assemble the nanodiscs. As shown in Figure 3.2.3, firstly, by using a
nickel affinity column, the empty nanodiscs was separated from the P450 Nanodiscs due
to a histidine tag attached on the target protein. Then the further separation was done by
loading fractions on a size exclusion chromatograph to get a correct size of CYP17
nanadiscs monomers. The ideal size is around 10nm. The SDS-PAGE gel shows the
target protein CYP17 was successfully incorporated into nansodics.

Figure 3.2.3 Preparation of CYP17 nandiscs.
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3.2.2 Reconstitution of cyt b5 with manganese protoporphyrin IX

Cyt b5 was reconstituted with Mn-protoporphyrin IX according to previously
published protocol,83 with the following changes: After performing buffer exchange with
G-25 column to separate unbound Mn-protoporphyrin IX, the eluate was run through a
DEAE-cellulose column, equilibrated with 25 mM Tris acetate (pH 8.0), 1 mM EDTA
and 10 mM sodium cholate. A linear salt gradient was formed using the equilibration
buffer supplemented with 1 M NaCl. Mn-b5 fractions which were characterized on the
basis of their observed Rz ratios, were pooled and rigorously dialyzed against 100 mM
potassium phosphate buffer (pH 7.4) and flash frozen in liquid nitrogen before being
stored at 80C until use.
3.3.3 Preparation of Raman samples

3.3.3.1 Preparation of ferric form

CYP17A1 incorporated in Nanodiscs in 100 mM potassium phosphate buffer (pH
7.4) was concentrated to 200 M and 2-foldexcess of Mn-b5 was added from a 400 M
solution in the same buffer. The resultant solution incubated at 37C for 15 min. As shown
in Figure 3.2.4, both cyp17 and Mn b5 are successfully incorporated into nanodiscs, with
their distinct bands. Substrate was added to each sample from methanolic stocks such that
the final concentration was 420 M.98 Finally, ultrapure glycerol was added to a
concentration of 15% (v/v); i.e., the final concentration of CYP17A1 was calculated to be
85 M. The samples were flash frozen in liquid nitrogen and stored at 80C until
analyzed.
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Figure 3.2.4 SDS-PAGE gel of ND: CYP17 with Mn b5.

3.3.3.2 Preparation of ferrous dioxygen adduct

To better investigate effects of cytochrome b5 on the H-bonding interactions in the
CYP17 distal pocket, two substrates, 17α-hydroxyprogesterone (OH-PROG) or 17αhydroxypregnenolone (OH-PREG) were incubated with ND: CYP17 samples in presence
Mn b5. Samples for rR spectroscopy measurement contain 250 μM ND: CYP17, 0.1 M
potassium phosphate, pH 7.4, 0.2 M NaCl, and 400 μM of 17α-hydroxyprogesterone or
17α-hydroxypregnenolone (Sigma Aldrich). Solutions were prepared in distilled 30%
(v/v) glycerol in H2O buffer. Starting with the degassing samples by connecting the NMR
tube to the vacuum line, then refilling the argon gas. This process is repeated for three

63
times to eliminate the possibility that presence of oxygen. Samples were reduced under
anaerobic conditions by titrating with a 0.9~1 fold molar excess of sodium dithionite in
the presence of 6.25 μM methyl-viologen. It is important to note that the carefully
performed titration ensures the reduction only performs on CYP17 as the redox potential
of the enzyme is more positive than Mn b5. Each sample reduced at room temperature
and then transferred to a dry ice-ethanol bath held at -20 °C where it was cooled for 2
minutes. Oxy-ferrous complexes were formed by bubbling 16O2 or 18O2 for 7 seconds,
followed by rapid freezing in liquid N2.
3.3.4 Resonance Raman Measurement

To determine the effect of cyt b5 on the heme stretching modes in ferric
CYP17A1, we employed the Mn reconstituted form of cyt b5. This was done to prevent
interference from the heme of cyt b5 as was done previously by Mak et al in rR studies on
CYP2B4.98 99 We acquired resonance Raman spectra after adding 2-fold and 4-fold
excess of Mn b5. The high frequency spectra were acquired using the 406.7 nm excitation
line from a Krypton ion laser (Coherent Innova Sabre Ion Laser) and changes in the (FeS) stretching mode were investigated 356.4 nm excitation line from the same laser, a
wavelength known to selectively enhance this mode.39 Resonance Raman spectra of
frozen dioxygen samples were obtained using the 413.1 nm excitation line from a Kr+
laser, which effectively enhances internal modes of the Fe-O-O fragment. Each oxy
sample was measured for 12hrs to obtain a better S/N signal, with a very low power
maintained at 1mW on the sample. The rR spectra of all samples were measured using a
Spex 1269 spectrometer equipped with a Spec-10 LN liquid nitrogen-cooled detector
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(Princeton Instruments, NJ). The laser power was adjusted to ~10 mW. All samples were
measured in a spinning NMR tube to avoid local heating and protein degradation. The
spectra were collected using a 180° backscattering geometry, and the laser power was
focused on the sample with a line image using a cylindrical lens. Spectra were calibrated
with data acquired for fenchone and processed with Grams/32 AI software (Galactic
Industries, Salem, NH).
3.3 Results and Discussion

3.3.1 NADPH oxidation and catalytic turnover of 17ahydroxypregnenolone in the
presence of cyt b5 or Mn-b5 (Collaboration with Dr. Sligar’s group)

The rates of NADPH oxidation and product formation in the presence of cyt b5
and Mn-b5 were compared to the rates in the absence of any added cyt b5. The presence
of cyt b5 increases the product formation rate ~5 fold, while the addition of Mn-b5 does
not cause any change (Fig. 3.3.1 A). The rates of NADPH oxidation were close in value
in all three cases, 54 ± 1.3 min-1 for cyt b5, 51 ± 1.0 min-1 for Mn-b5 and 46 ± 1.9 min-1
for reactions in the absence of any b5. The efficiency of coupling was calculated as the
ratio of product formation rate to the rate of NADPH consumption. This was seen to be
maximal in the reactions with cyt b5, while reactions with no b5 and with Mn-b5 had
similar coupling efficiency (Fig. 3.3.1 B).
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Figure 3.3.1 Comparison of CYP17A1 catalyzed lyase reactions with 17a-hydroxypregnenolone as substrate, with no cytochrome b5 present, or with Mn-b5, or native
cytochrome b5. (A) DHEA product formation rates (B) Coupling efficiencies (calculated
as the percent ratio of amount of product formed to the amount of NADPH consumed).
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3.3.2 Resonance Raman spectroscopy on Mn b5 binding to ferric CYP17A1

As was reported in an earlier work,100 binding of pregnenolone to substrate-free
CYP17A1 causes a spin state conversion from almost pure low spin (LS) to largely high
spin (HS) form, while binding of 17-hydroxypregnenolone generates a lower HS
fraction. The persistence of more LS component being attributed to the tendency of the
17-hydroxy fragment of the substrate to directly interact with the heme iron or promote
retention of distal pocket water molecules. In the present work, additions of Mn-b5 to
substrate-bound forms of CYP17A1, creating 2-fold excesses relative to the enzyme,
cause relatively small increases of the LS component in these samples. This is reflected
in the resonance Raman (rR) spectra illustrated in Fig. 3.3.2 for the samples bearing a 2fold excess of Mn-b5. As can be seen in trace B, pregnenolone bound CYP17A1
interacting with Mn-b5 shows a spectrum similar to that for the sample without Mn-b5
(trace A); they both exhibit a strong isolated 3 mode at 1488 cm-1 and a small signal for
LS population near 1500 cm-1. Employing a procedure developed in our laboratory by
Mak et al., it is possible to estimate the spin state population using the intensity ratio of
IHS/ILS equal to 1.24.101 Using this value, the HS population of pregnenolone bound
CYP17A1 in the presence of a 2-fold excess of Mn-b5 is calculated to be 80%, close to
the value observed in the absence of Mn-b5. Similarly, it is noted that the HS component
changes from ~57% to ~50% when a 2- fold excess of Mn-b5 was added into 17hydroxypregnenolone bound CYP17A1 (Fig. 3.3.2 right panel, trace D). These remained
nearly the same even in the presence of 4-fold Mn-b5, indicating that all of CYP17A1
binding sites for cyt b5 have been occupied. In addition to the relatively minor effects on

67
spin state populations, as can be seen in Fig. 3.3.2, it is important to emphasize that the
frequencies observed for both the low energy and high energy internal modes of the heme
prosthetic group do not shift relative to those observed for the corresponding samples
without Mn-b5, implying that the interaction with Mn-b5 does not induce significant
structural changes of the heme macrocycle or its peripheral substituents in the substratebound ferric enzyme. Though minimal effects were observed for spin state populations
and heme structure, it is noted that association of CYP17A1 with Mn-b5 increases the
strength of Fe-S linkage, demonstrating the formation of a CYP17A1: Mn-b5 complex.
This is evident from viewing the inserts for the low-frequency spectra in Fig. 3.3.2, where
the  (Fe-S) stretching modes occurring in samples with the excess Mn-b5 appear at 350
cm-1, while those previously reported for the same samples of CYP17A1 in Nanodiscs
without Mn-b5 appear at 347 cm-1.100
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Figure 3.3.2 Resonance Raman Spectra of CYP17A1 +/- Mn b5 in 100 mM potassium
phosphate buffer (pH 7.4) containing 15% (v/v) glycerol. The right panel shows the highfrequency region of the acquired spectra, while the left panel shows the low frequency
region; the spectra were acquired using the 406.7 nm excitation line from a Krypton ion
laser, noting that the inset bands in the low frequency region were acquired with the
356.4 nm excitation line from the same laser, a wavelength that selectively enhances the
ν(Fe-S) stretching mode.39 Spectra traces in B and D are the resulting traces after
subtraction of spectra obtained for samples containing the equivalent concentration of Mn
b5 in 15% (v/v) glycerol in buffer.
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3.3.3 rR spectroscopy characterization of ferrous dioxygen intermediates of
hydroxylated substrates bound to CYP17 in the presence of Mn b5

In previous rR studies on CYP17 dioxygen adduct performed by our group,
different H-bonding interactions in the active site with a key Fe-O-O fragment of the
enzyme intermediates are demonstrated for OH-PROG and OH-PREG, which proves to
be a key factor that can control substrate processing.102 As mentioned earlier, CYP17 is
able to catalyze the lyase reaction on both OH-PROG and OH- PREG cleaving the 17–20
carbon–carbon bond to form dehydroepiandrosterone and androstenedione; however, it is
interesting to see that androgen formation is 50-fold greater with OH-PREG than for OHPROG, with the rR spectra of the dioxygen adducts of CYP17 offering a plausible
explanation for this differential behavior. As shown in Figure 3.3.3 and Figure 3.3.4, if
we just have PROG and PREG bound in the active site, virtually identical iron oxygen
and O-O stretching frequency. This is not surprising because they are known to dock
similarly. However, if OH-PROG and OH- PREG are bound in the enzyme, both of the
O-O stretching is shifting down slightly, but there is a quite significant difference in iron
oxygen stretching modes, the (Fe-O) frequency for OH-PROG going up and the
frequency for OH-PREG goes down, relatively to the ~535 cm-1 value seen for PROG
and PREG. That’s important, because DFT calculations showed that hydrogen bonds to
the proximal O of the Fe-OP-OT fragment can cause a decrease of Fe-O stretching mode
whereas H-bonding to the terminal O will shift up the Fe-O stretching mode. More
importantly, computational works done by Haris and Shaik show this kind of H-bonding
promotes lyase reaction, allowing the nucleophilic attack of the peroxo intermediate on
the 20-carbonyl.103,104 So this alone can explain why OH-PREG is much more effectively
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transformed to lyase product than is OH PROG. So resonance Raman to be an effective
way to detect subtle but functionally significant changes in the distal pocket environment.

Figure 3.3.3 The rR spectra of PROG- and 17-OH-PROG-bound O2 adducts of ND:
CYP17 in H2O buffer (Trace A and B, respectively).

Figure 3.3.4 The rR spectra of PREG- and 17-OH-PREG-bound O2 adducts of ND:
CYP17 in H2O buffer (Trace A and B, respectively).
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Though the presence of redox partner Mn cyt b5 does not appear to have a
significant effect on heme structure, based on the results present earlier in this chapter, a
more careful rR study applied to the OH-PROG and OH-PREG bound ND: CYP17
ferrous dioxygen complexes in presence of Mn cyt b5 was conducted here, attempt to
detect these subtle active site structural change caused by this redox partner. Shown in
Figure 3.3.5, is the rR spectra for the OH-PROG bound ND: CYP17 dioxygen complex
in presence of a two-fold excess of Mn cytb5. The key (16O-16O) mode still appears at
1131 cm-1, as confirmed by the 16O2/18O2 difference spectrum, while the (18O-18O)
stretching mode occurs at 1068 cm-1 (the expected 63cm-1 isotope shift). Expansion of
this spectral region, and comparison with the spectrum acquired with 18O2, shows
evidence for a minor conformer of Fe-O-O fragment with the (16O-16O) mode occurring
at 1140 cm-1, which is apparently unshifted from the values observed for OH-PROG in
the absence of this redox partner (Figure 3.3.3). Significantly, the sample prepared
including the Mn cyt b5 activates a new Fe-O-O conformer, with a (Fe-16O) mode at 530
cm-1 and a corresponding (Fe-18O) mode at 501 cm-1. This suggests that the interaction
with Mn cyt b5 causes a partial transformation to a conformer which provide an Hbonding interaction with the proximal oxygen, a structure which favor the lyase reaction.
Though the main compact of the redox partner was shown to be as an electron transfer
role from earlier functional studies,105 subtle allosteric role of the Mn cyt b5 is indicated
on OH-PROG bound enzyme.

Corresponding spectral data for 17-OH PREG bound enzyme in presence of Mn
b5 is shown in Figure 3.3.6. The (16O-16O) and (Fe-16O) modes are observed at 1135
cm-1 and 526 cm-1, corresponding to the isotope band (18O-18O) and (Fe-18O) occur at
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1070 cm-1 and 497 cm-1, which are unshifted from their values in the sample without the
redox partner. Thus, addition of Mn cyt b5 does not cause any spectral difference, the lack
of effects on the Fe-O-O fragment further suggesting that the electron transfer role of the
redox partner dominates for this substrates.

Figure 3.3.5 rR spectra of OH-PROG bound ND: CYP17 oxy complex in presence of 2
fold excess of Mn b5 in mid-frequency region. Spectra were measured at liquid nitrogen
temperature with excitation line at 413.1 nm. (A) OH-PROG bound ND: CYP17 16O2
complex, (B) OH-PROG bound ND: CYP17 18O2 complex, (C) difference spectra: trace
A-trace B.
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Figure 3.3.6 rR spectra of OH-PREG bound ND: CYP17 oxy complex in presence of 2
fold excess of Mn b5 in mid-frequency region. Spectra were measured at liquid nitrogen
temperature with excitation line at 413.1 nm. (A) OH-PREG bound ND: CYP17 16O2
complex, (B) OH-PREG bound ND:CYP17 18O2 complex, (C) difference spectra: trace
A-trace B.
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3.3.4 Discussion

CYP17A1 is a critical enzyme in steroidogenesis, lying at the branch point of
glucocorticoids synthesis and androgen synthesis. It performs hydroxylation on the
pregnene-nucleus to form hydroxylated products which can either be diverted to
glucocorticoid synthesis, or undergo a C-C bond lyase reaction to produce androgens.
Cytochrome b5 is known to be the chief regulator of CYP17A1 reactivities in vivo, yet
the nature of interactions of CYP17A1 with cyt b5 is not clearly understood. Cyt b5 is
known to enhance the lyase reactions from 5 to 10 fold. Whether cyt b5 acts as an
allosteric modulator or if it functions as a second electron donor has long been debated,88
89

and conflicting reports from various groups are complicated by the fact that these

studies were carried out in uncontrolled conditions where aggregation states and
stoichiometries of interactions were not known.88 106 107 Scott and coworkers have used
solution NMR with soluble forms of the proteins to study the conformational changes
occurring in CYP17A1 bound to lyase substrates upon cyt b5 binding and associated them
with an allosteric role for cyt b5,108 102 although not directly addressing a possible redox
role. The application of Nanodisc technology to this system is therefore an effective
solution, enabling us to study reactions in controlled stoichiometries in a native-like
membrane environment.
We reconstituted cyt b5 with Mn-protoporphyrin IX, which is known to be redox
inactive under these conditions,83 and tested the rate of lyase reaction in 17hydroxypregnenolone in the presence and absence of cyt b5, and also in the presence of
Mn-b5. Reactions with Mn-b5 showed no enhancement of the rate of DHEA formation,
which suggests very strongly that cyt b5 has a definite redox donor role in the CYP17A1
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lyase chemistry. Importantly, presence of cyt b5 increases the coupling efficiency about
5-fold. Given the relatively high redox potential of cyt b5 (~0 mV NHE),81 its redox role
is limited to reduction of the oxy-complex,82 giving rise to the nucleophilic peroxospecies, the reactive intermediate responsible for carbon-carbon bond scission.109 110 An
enhanced reduction rate of the oxy-complex is expected to increase the steady-state
concentration of the peroxoanion, which in the absence of cyt b5 is depleted through nonproductive release of hydrogen peroxide. Our resonance Raman data with Mn-b5 binding
to ferric CYP17A1 indicate no major structural changes of the heme planar modes,
whereas on the proximal side, Fe-S bond was observed to get strengthened when Mn-b5
was bound. Clearly, Mnb5 binds to CYP17A1, but is incapable of enhancing the lyase
activity, the latter being enhanced if the native iron containing cyt b5 is bound. The
ferrous dioxygen adduct of OH-PROG CYP17 in presence of a 2 fold Mn cyt b5 exhibits
slight change in the active site, showing allosteric role of redox partner. However, the rR
data of oxy OH-PREG enzyme with Mn cyt b5 strongly supports the electron transfer
role. Taken together, these experiments provide strong evidence that cyt b5 is serving as a
redox partner in CYP17A1 catalytic cycle, most likely delivering a second electron to the
oxy-complex and facilitating formation of the peroxo-ferric complex, which recent
evidence shows to be the catalytically active intermediate in the lyase reaction.109 This
result is in agreement with conclusions on the role of cyt b5 in CYP2B4 catalysis.111,89
Although our results cannot disprove the presence of functionally important allosteric
interactions between cyt b5 and CYP17A1, the lack of any effect of Mn-b5 on the rate of
turnover of 17-hydroxypregnenolone, as compared with 5-fold acceleration of this
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reaction in the presence of cyt b5, suggests that these allosteric interactions do not play
significant role in the human CYP17A1 mediated catalysis of lyase reaction.
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Chapter 4. Resonance Raman studies on Cytochrome P450 from Bacillus
megaterium (P450 BM3) and some biotechnologically important mutants

4.1 Introduction

The cytochromes P450 comprise a huge class of heme containing
monooxygenases which collectively exhibit a diverse range of chemical reactivity in
numerous organisms, facilitating important physiological functions, including the
metabolism of pharmaceuticals and various toxic compounds.9, 45 One essential catalytic
activity of these enzymes is the insertion of an atom of molecular oxygen into a relatively
inactive C-H bond, thereby effecting a hydroxylation reaction on otherwise inert
substrates; e.g. fatty acids.31 Furthermore, over the past several decades, a number of
bacterial P450s have been shown to play key roles in many physiological processes; e.g.
antibiotic synthesis and catabolism of complex molecules (e.g. steroids). Moreover,
typically they display diverse regio- and stereoselectivity in the oxidation of a wide range
of substrates,112 a finding which has attracted growing attention from an industrial
perspective, especially through use of protein engineering as an effective approach for
important applications of microbial P450s in biotechnology.
The bacterial enzyme P450 BM3 first isolated from Bacillus megaterium,
catalyzes the hydroxylation and epoxidation of hydrophobic long-chain fatty acids.113
There is currently high interest in this enzyme owing to its remarkably high
monooxygenase catalytic activity, which results mainly from the fact that it possesses a
covalently linked, high activity cytochrome P450 reductase (CPR) partner, such an
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arrangement providing extremely efficient electron transfer between the CPR and the
P450.114 Furthermore, its demonstrated ability (in wild-type and mutant forms) to
catalyze oxidation of diverse substrates with high degrees of regio- and stereo-selectivity
greatly enhances its potential for biotechnologically useful applications.115 Examples
include the utility of BM3 mutants in converting testosterone to 2-hydroxytestosterone
and 2-hydroxytestosterone,116 and particularly in producing human drug metabolites,
such as those from PPI (proton pump inhibitor) drug molecules. These kinds of
industrially important molecules are typically prepared by complicated and expensive
methods of traditional synthetic chemistry.117 Indeed, much effort has already been
devoted to studies of this particular BM3 mutants to synthesize metabolites of
omeprazole (OMP) (Figure 4.1.1), and of other PPI molecules.118 With reference to the
P450 BM3 heme domain crystal structure (Figure 4.1.2), the role of active site residues
have been extensively explored,119 with residues near the active site pocket, including
Phe87and Ala82, having been targeted in attempts to alter substrate selectivity and enzyme
activity.120 For example, Phe87 is located over the heme cofactor and plays a key role in
interacting with the -methyl group of the fatty acid substrate, preventing its oxidation.
Mutating the phenylalanine provides new space close to the heme cofactor to allow
binding of novel substrates. The A82F mutant causes moderate destabilization of the
BM3 heme domain structure by inducing a conformational change.121 Collectively, these
effects lead to pronounced changes in the substrate specificity profile of the F87V/A82F
double mutant. It is of note that both of the A82F and F87V single mutants demonstrate
affinity for omeprazole, as measured by the development of high-spin heme in these
samples on titration with omeprazole, with Kd values of 1.67 ± 0.05 M and 49.0 ± 2.7
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M, respectively.120 However, the combined mutations lead to much higher affinity for
omeprazole in the F87V/A82F double mutant (Kd = 0.212 ± 0.014 M). All of the
mutants catalyze hydroxylation on the 5-methyl group of omeprazole, with the
F87V/A82F double mutant being the most productive enzyme. The 5-hydroxylation of
omeprazole is the same reaction catalyzed by CYP2C19, the major human omeprazole
metabolizing P450.120 The effects of various alterations on the structure and environment
in the active site of these mutants are of great interest.
Among the many diverse spectroscopic methods, resonance Raman (rR)
spectroscopy has proven itself to be a highly effective approach by which the active site
environment of a heme protein can be interrogated. This technique can selectively
enhance the heme vibrational modes by adjusting the excitation line close to the heme
absorption bands.2, 122 Information such as oxidation state and spin state of the heme iron
can be readily obtained using the so-called marker modes, which appear in the high
wavenumber region of the vibrational spectrum, while the low wavenumber region can
provide important insight into the interactions between protein residues and the
peripheral heme groups; i.e., the vinyl and propionate substituents. This is important,
because the relative orientation of these groups can affect the reactivity of heme.123
Moreover, this technique is particularly useful for analyzing changes in the disposition of
exogenous axial ligands caused by binding of substrates, and for examining differences in
the active site environment, including distal pocket polarity and steric interactions,
imposed by the substrate or amino acid residues.57
In the present study, rR spectroscopy is used to probe heme structure and
coordination environment for selected mutants (A82F, F87V and the F87V/A82F double
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mutant) of the BM3 heme domain in their substrate-free and substrate-bound forms. The
substrate selected is omeprazole (OMP), which was shown to bind to the mutant forms of
the BM3 heme domain by UV-visible spectral titration, but which did not induce any
significant shift towards high-spin heme iron in the wild type BM3 heme domain.
Specifically, rR spectral data were acquired for the substrate free (SF) and OMP-bound
forms of the wild type and mutant BM3 heme domains. Furthermore, the rR of ferrous
CO adducts were also collected and analyzed in order to interrogate how omeprazole
substrate binding affects the vibrational modes of the Fe-CO molecular fragment, data
which reveal important details about the active site architecture. Collectively, these
studies provide insight on how these ‘gatekeeper’ mutants influence substrate selectivity,
affinity and protein-heme interactions within the BM3 heme domain active site.

Figure 4.1.1. Structure of human drug OMP (omeprazole). Hydroxylation on the 5methyl group is performed by engineered variants of P450 BM3 mutants.
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Figure 4.1.2. Structure of omeprazole bound A82F/F87V double mutant of P450 BM3.
Key residues are shown as blue sticks. Phe82 and Val87 are shown in green, close to the
heme. Other important residues include Ser72, which participates in a hydrogen bonding
network involving active site water molecules, benzimidazole and pyridinyl group
nitrogens, and a heme propionate. Leu437 also hydrogen bonds to the other
benzimidazole group nitrogen atom through its backbone carbonyl group, while Thr268
plays a key role in proton delivery to heme iron-oxo species during the P450 catalytic
cycle. (PDB #: 4KEY)120

4.2 Experimental

4.2.1 Samples preparation for rR measurement

Samples of P450 BM3 heme domain and its mutants, generated using previously
described procedures,120 were used to prepare samples for rR measurements. Specifically,
50 L of 100 M P450 BM3 (heme domain) samples of the substrate-free wild type, the
single mutants A82F and F87V BM3, and the double mutant F87V/A82F heme domains
were transferred into NMR tubes for rR measurements. The substrate stock solution was
prepared by dissolving 9 mg of omeprazole in 450 L of DMSO to reach a concentration

82
of 56.4 mM. The substrate/enzyme ratio is 5.6/1 in substrate-bound samples. The sample
was centrifuged and the transparent supernatant solution was transferred to an NMR tube
for rR measurement.
The carbon monoxide complexes of the heme domain of ferrous BM3 (wild type
and mutant heme domaims) were prepared with and without the substrate, omeprazole.
To prepare these samples, NMR tubes were sealed with a rubber septum and CO gas was
introduced to the solution using a long needle for 20 minutes to remove oxygen. Then
samples were reduced with a 2-fold excess of degassed sodium dithionite solution and
CO gas was further bubbled for an additional 10 minutes before measuring the rR
spectra.
4.2.2 Resonance Raman measurement

The ferric sample was measured with the 406.7 nm excitation line from a Kr+
laser (Coherent Innova Sabre Ion Laser) while the spectra of the Fe(II)-CO adducts were
acquired with the 441.6 nm line from a He-Cd laser (IK Series He−Cd laser, Kimmon
Koha Co., Ltd.). All spectra were measured using a Spex 1269 spectrometer equipped
with a Spec-10 LN liquid nitrogen-cooled detector (Princeton Instruments, NJ). The slit
width was 150 μm and the laser power incident on ferric samples was ~10 mW, while the
power used for ferrous-CO samples was adjusted to ~1 mW at the samples to prevent CO
photo-dissociation. Rayleigh scattering was removed from the Raman signal by using an
appropriate notch filter (Kaiser Optical). The samples were placed in a N2–driven
spinning NMR tube and the spectra were collected by using a 180° backscattering
geometry with a cylindrical lens to achieve a line focus on the tube. Spectra were
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calibrated with data acquired for fenchone and processed with Grams/32 AI software
(Galactic Industries, Salem, NH).
4.3 Results and discussion

4.3.1 Effects of omeprazole binding on the ferric form of WT P450 BM3 heme
domain and its mutants

The rR spectra of the ferric wild-type substrate-free enzyme and its omeprazolebound form are shown in Figure 4.3.1. The spectrum of the substrate-free sample (trace
A) exhibits the oxidation state marker mode ν4 at 1372 cm-1 and the ν3 and ν2 spin-state
markers at 1501 and 1585 cm-1, respectively, confirming the presence of a pure six
coordinate low-spin (6cLS) species. The spectrum of the BM3 heme domain with
omeprazole (trace B) exhibits a spectral pattern essentially identical to that of the
substrate-free sample, indicating that the addition of omeprazole causes no changes to the
heme spin state or to the macrocyclic core structure. As shown in Figure 4.3.1,
comparisons of both the low-wavenumber and high-wavenumber rR spectral data also
confirm the lack of significant changes induced by omeprazole, as judged by the virtually
identical rR spectra shown in traces A and B. Thus, the rR spectra of ferric wild type
BM3 heme domain show no indication of heme spectral changes upon addition of OMP,
a finding which is consistent with earlier published results, where optical titrations
showed no evidence for binding of OMP to WT BM3.120
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Figure 4.3.1 rR spectra of various form of wild type P450 BM3. (A) substrate-free form
(B) OMP-bound. Left panel shows the low-wavenumber region while the right panel
shows the high-wavenumber region.
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Figure 4.3.2. High wavenumber rR spectra of substrate-free ferric P450 mutants and
their substrate bound forms. (A) A82F substrate-free form. (B) Omeprazole bound A82F.
(C) F87V substrate-free form. (D) Omeprazole bound F87V. (E) A82F/F87V double
mutant substrate-free form. (F) A82F/F87V double mutant omeprazole bound form. All
spectra were normalized to the 4 mode.
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4.3.2 Active site structural changes of P450 BM3 mutants induced by omeprazole
binding

The high-wavenumber rR spectrum of substrate-free A82F BM3 heme domain
mutant is shown in Figure 4.3.2 (A), where assignments of the observed bands are given,
all of which are consistent with earlier published data for CYP101A1 (the camphor
hydroxylase P450cam) and the general behavior of  (C=C) modes.124-125 The strongest
peak occurs at 1373 cm-1 and is assigned as the oxidation state marker band, 4,
confirming that the protein is in the ferric state. The spin state marker bands, and
10, occur at 1501 cm-1, 1582 cm-1 and 1637 cm-1 respectively, consistent with a six
coordinate, LS heme iron. However, weaker peaks at 1486 cm-1 and 1568 cm-1 indicate
the presence of a small percentage of a high spin five coordinate (5cHS) species. It is
possible to estimate the spin state population in this sample using previously derived
relative rR scattering cross section of the v3 modes for the 6c LS and 5c HS species, as
determined for both forms of P450cam, and as described by Mak et al.101 Using this
procedure, the HS percentage is calculated to be 30%. In contrast with most other
substrate-free P450s (which often yield a more extensive LS population), this A82F
mutant retains a significant percentage of HS state, even after having been passed through
a Lipidex column to facilitate removal of any lipid substrate. X-ray crystallography
data120 reveal that the structure of the substrate-free A82F heme domain is significantly
different from that of the substrate-free WT BM3 heme domain. Specifically, a
displacement of the FG helix region is seen, which disrupts the contacts between the FG
helices and the I helix, leading to the reorientation of hydrophobic residues within the
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active site and a conformational change in the P450. It appears likely that this dramatic
structural change may affect the organization of the cluster of water molecules in the
distal pocket above the heme, as a consequence of the movement of I helix; i.e.,
hydrogen-bonding networks are disrupted and rearranged, altering the positions of water
molecules. Thus, the substrate-free A82F mutant exists naturally in equilibrium between
the LS and HS state.
Typically, binding of substrates to the cytochromes P450 causes a ferric heme
iron spin state change from 6cLS towards 5cHS owing to the disruption of the water
cluster in the distal pocket and through the displacement of the axial water ligand.
Usually, there is a corresponding increase in the heme FeIII/FeII redox potential that helps
facilitate electron transfer to the heme iron from the relevant redox partner.126 As shown
in Figure 4.3.2 (B), addition of OMP to the A82F mutant causes significant changes in
the high-wavenumber rR spectrum. Two 3 modes, observed at 1486 cm-1 and 1501 cm-1,
show that the OMP-bound form also exists in an equilibrium between the 5cHS and 6cLS
forms, respectively. The relative intensity of the HS 3 (1486 cm-1) band is larger
compared to the LS 3 (1502 cm-1) mode, indicating a higher population of the HS
component, estimated to be 65%.101 This spin state mixture is also reflected in alterations
in the 2 and ν10 bands; i.e., the 2 bands occur at 1568 cm-1 (HS) and 1582 cm-1 (LS). In
the WT P450 BM3 protein, the Ala82 residue is located in a peripheral position in the
active site. However, mutating Ala82 to a bulky phenylalanine leads to a substantial
conformational change, altering positions of key active site residues (Figure 4.3.3), In
particular, the Phe87 residue adopts a different conformation in which its side chain
flipped from a parallel position to a near perpendicular orientation relative to the heme
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plane, as compared to wild type BM3 heme domain in its complex with Npalmitoylglycine substrate (NPG) (PDB: 1JPZ). This structural change provides a closer
contact of the phenylalanine side chain with the pyridinyl moiety of OMP, inducing a
reorientation of substrate, leading to an increased HS component.

Figure 4.3.3 Stereoviews of A82F/OMP BM3 heme domain active site (PDB 4KEW in
red) with WT/NPB BM3 active site (PDB 1JPZ in blue). Key amino acid residues in
lines.

Similar studies of the F87V P450 BM3 heme domain mutant were conducted,
with the high-wavenumber region of the substrate-free form (Figure 4, trace C) exhibiting
features characteristic of the ferric state, with the ν4 oxidation state marker occurring at
1373 cm−1. The spin state marker bands, including ν3 at 1501 cm−1, ν2 at 1583 cm−1 and
ν10 at 1637 cm−1, are indicative of a pure 6cLS state, consistent with heme iron
coordination by a water molecule associated with a distal pocket cluster of water
molecules.127 The feature observed at 1621 cm−1 is confidently assigned to the ν(C=C)
stretching mode of the peripheral vinyl group, with this wavenumber corresponding to an
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in-plane vinyl stretching mode.128 Binding of OMP to F87V BM3 causes a partial
conversion from 6cLS to 5cHS, as shown in Figure 4.3.2 (trace D), with the 5cHS
markers being observed at 1486 (ν3), 1568 (ν2), and 1622 cm−1 (ν10) (the last being
overlapped with vinyl v(C=C) mode(s)). The weak 6cLS markers seen at 1501 and 1583
cm−1 persist in the spectrum, confirming the presence of residual low spin species.
Overall, the increase of the HS component (56%) indicates the ability of this mutant to
allow access of OMP to the heme distal pocket.
Turning attention to the substrate-free A82F/F87V double mutant, the enzyme
exhibits a pure ferric 6cLS state, as evidenced by an isolated band at 1500 cm-1. Binding
of OMP to the double mutant gives rise to a relatively large HS component, exhibiting a
ν3 feature at 1486 cm-1, as shown in Figure 4.3.2 (trace F). The intensity analysis
referenced above16 provided a calculated ratio of 68% of the HS form. It is noted that the
wavenumbers of the vinyl stretching modes in the spectra of substrate-bound samples are
difficult to establish because of their overlap with the HS ν10 mode; i.e., the ν10 mode for
5cHS is expected to occur near 1623 cm−1.129,130
Summarizing the results obtained for the ferric proteins in the high-wavenumber
region of the rR spectra, while binding of OMP is rigidly restricted for WT BM3, all of
the F87V, A82F and F87V/A82F mutants show a considerable spin state conversion upon
binding OMP, consistent with entry of OMP into the active site. However, a significant
percentage of 6cLS species exists, possibly resulting from the incomplete expulsion of
water molecules from the pocket and retention of an axial water ligand in minor
proportion of the enzymes. However, a substrate conformation in which the pyridinyl
nitrogen atom of OMP is in a position to coordinate with the heme, thereby generating a
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LS species, cannot be ruled out. The percentages of the HS fractions for all of the BM3
heme domain samples (in substrate-free and OMP-bound forms) are summarized in the
Table 1. These results obtained from resonance Raman data are in good agreement with
earlier published binding data based on optical studies of OMP binding. These Kd data
are also included in Table 1, clearly demonstrating that the F87V, A82F and combined
F87V/A82F double mutations enable this fatty acid hydroxylase enzyme to act as a
catalyst for OMP hydroxylation. The A82F substrate-free sample shows ~30% HS
content, whereas the DM shows negligible HS content after treatment with Lipidex. It is
likely that the introduced Val87 residue in the F87V/A82F double mutant alters distal
pocket organization such that the spin-state equilibrium is perturbed as a result of
reorganization of water molecules in the environment of the heme.

Table 4.3.1. P450 BM3 wild-type and mutant heme domain spin state populations,
calculated by cross section ratio 1.24. The table shows the high spin proportion of the
different mutants, along with Kd values for OMP binding to mutant heme domains. NA
indicates that no evidence of binding was found.
Protein
Wild type
Wild type
A82F
A82F
F87V
F87V
A82F/F87V DM
A82F/F87V DM

substrate resonance Raman (%HS)
SF
0%
OMP
0%
SF
30%
OMP
65%
SF
0%
OMP
56%
SF
0%
OMP
68%

Kd values from optical data120
NA
1.67± 0.05
49± 2.7
0.212± 0.014

Low frequency Resonance Raman spectra. The low-wavenumber region of rR
spectra can provide important information about the disposition of heme peripheral
groups. Specifically, the propionate groups usually exhibit their vibrational modes in the
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region of ~360-380 cm-1, providing insight into their interactions with the protein, mainly
involving hydrogen bonding interactions with the surrounding amino acid residues which
causes rR shifts to higher wavenumbers. In the 400-440 cm-1 region, the bending modes
of vinyl groups occur, with the lower wavenumber mode (near 410 cm-1) corresponding
to the in-plane orientation, while the higher wavenumber mode (near 440 cm-1) is
associated with an out-of-plane distortion.131, 132 In addition, structure sensitive in-plane
and out-of-plane (i) heme deformation modes occur in this region.133, 134
As shown in Figure 4.3.4, trace A, the substrate-free A82F BM3 lowwavenumber rR spectrum shows the normal heme skeletal modes: 7 (676 cm-1), 15 (753
cm-1) and 8 (344 cm-1). According to more detailed assignments of the rR spectra of
other P450s, such as P450cam,125 the bands observed at 364 cm-1 and 380 cm-1 are
assigned to the bending modes of two heme propionate groups, while the band at 429 cm1

is assigned to an out-of-plane vinyl bending mode, which can be correlated with the

vinyl stretching mode observed at 1621 cm-1 in Figure 4. The binding of OMP causes an
increase in the intensity of the 365 cm-1 bending mode of propionate group(s), indicating
structural reorientation and a perturbed hydrogen bonded propionate group(s). A similar
pattern was observed in the spectrum of substrate bound P450 BM3, this mode is
originally assigned as an out-of-plane 6 mode by Deng et al,135 which is induced by
binding of the substrate. However, Schelvis and coworkers132 assign this substrate activated
mode to be a new propionate mode, result from a disrupted H-bonding between 7-propionate and
lysine amino acid residue (Lys69), supported by crystallographic data.136 Finally, as confirmed by
Mak et al by employing a deuterated heme and a carefully performed deconvolution procedure,
this feature is believed to contain contributions from both the 6 and propionate mode.125
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Another bending mode of the propionate group(s) is observed at the same position as in
the substrate-free form (at 380 cm-1). Two bending modes of vinyl groups are detected at
414 cm-1 and 430 cm-1.124 Additionally, it is noted that a heme out-of-plane mode 7,
occurring at 312 cm-1, is activated after binding of OMP, which apparently induces an
out-of-plane distortion of the heme, i.e. the enhancement of out-of-plane modes arises
from an out-of-plane heme distortion of the equilibrium structure of the heme
macrocycle.26,27,137
Similar patterns are seen for the F87V mutant and for the A82F/F87V double
mutant heme domains (Figure 4.3.4, trace C-F). In both cases, introduction of OMP
(Figure 4.3.4 trace D and F) causes significant change in their low-wavenumber regions
compared to the substrate-free forms.
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Figure 4.3.4. Low frequency rR spectra of substrate-free ferric P450 mutants and their
substrate bound forms. (A) A82F substrate-free form. (B) Omeprazole bound A82F. (C)
F87V substrate-free form. (D) Omeprazole bound F87V. (E) A82F/F87V double mutant
substrate-free form. (F) A82F/F87V double mutant omeprazole bound form. All spectra
were normalized to the 7 mode.
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4.3.3 Ferrous CO P450 BM3 wild-type and mutant (A82F, F87V, A82F/F87V DM)
and their interaction with substrate.

Cytochromes P450 are able to bind gaseous diatomic ligands, such as CO, NO
and O2, among which the ferrous-CO adducts are relatively more stable, facilitating
detailed rR spectroscopic studies.59 This is fortunate, because the behavior of the
observable ν(Fe-C) and ν(C-O) stretching modes of the Fe-C-O fragment can provide
quite useful information about steric hindrance and H-bonding interactions imposed upon
the Fe-C-O fragment by the substrate or by surrounding amino acids within the active
site.138 The effects of such interactions are directly related to corresponding interactions
with the Fe-N-O and Fe-O-O fragments of the more unstable NO and O2 adducts. The
interaction between the heme iron and the bound CO involves heme dπ back- bonding to
the π* orbital of the CO ligand, strengthening the Fe-C bond while weakening the C-O
bond; this is reflected by an increased Fe-C stretching wavenumber and a decreased ν(CO) stretching mode, leading to the well-documented inverse linear correlation plot,
discussed in more detail later.57,139
The low wavenumber rR spectra of the ferrous CO adduct of wild type substratefree BM3 heme domain is shown in Figure 4.3.5 (Trace A, left panel). The most intense
band in this region, besides the 7 mode, is the (Fe-C) band seen at 471 cm-1. In
accordance with earlier work performed, including 13CO labeling, the band at 559 cm-1 is
assigned to the (Fe-C-O) bending mode, with the corresponding ν(C-O) mode occurring
at 1943 cm-1, as shown in Figure 4.3.5 (Trace A, right panel).
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A similar spectral patten is seen in the low wavenumber region of the rR spectra
of wild type BM3 with OMP (Figure 4.3.5, trace B), where the (Fe-C) stetching mode
occurs at 471 and the ν(C-O) mode at 1943 cm-1. Thus, introduction of OMP into the
wild type BM3 does not cause any significant change in the distal pocket, which is
consistent with other documented lack of evidence for the binding of OMP to the wildtype BM3. It is emphasized that this seemingly “redundant” information is actually
useful, because it is possible that binding of a substrate may not cause significant changes
in the spin state of the ferric form, but much less likely that binding of substrate would
not affect the modes of the Fe-C-O fragment in the P450. Thus, the absence of changes in
these modes provides stronger confirmation of the lack of OMP binding in the active site.

Figure 4.3.5 The rR spectra of ferrous CO adducts of wild type BM3, the low frequency
spectra is shown in left panel, and the high frequency is in right panel. (A) Wild type
substrate-free (B) wild-type OMP bound. Spectra were measured with 442 nm excitation
line and normalized to the v7 modes.
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Figure 4.3.6 The low frequency (left panel), middle frequency (mid-panel) and high
frequency (right panel) rR data of ferrous CO adduct of P450 BM3 mutants. (A) A82F
substrate-free form. (B) Omeprazole bound A82F. (C) F87V substrate-free form. (D)
Omeprazole bound F87V. (E) A82F/F87V double mutant substrate-free form. (F)
A82F/F87V double mutant omeprazole bound form. All spectra were normalized to the
7 mode.
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Figure 4.3.6 shows the rR spectra of the ferrous CO adduct of the BM3 mutants in
both the low wavenumber (left panel) and the high wavenumber regions (right panel). It
is important to note that binding of OMP to the ferrous CO forms of all these mutants has
no impact on the heme core modes, including the propionate modes and the orientation of
vinyl modes (Figure 4.3.6, left panel). This means that the bound substrate OMP mainly
interacts with the Fe-CO fragments within the active sites of the BM3 mutant heme
domains.
While the effect of OMP binding on the heme moiety is minimal, binding of OMP
has a significant impact on the Fe-C-O fragments of all of these mutants. As seen in the
low-wavenumber spectrum of the substrate-free form of the A82F ferrous CO adduct
(Figure 4.3.6, trace A), a single ν (Fe-CO) stretching mode occurs at 472 cm-1, with the
corresponding ν(C-O) mode being seen at 1947 cm-1, It is notable that these values are
quite similar to those of the substrate-free form of the WT heme domain (i.e., 472/1943
cm-1). However, addition of OMP causes substantial changes, as shown in Figure 4.3.6,
trace B. While the 472/1947 cm-1pair persists, a new ν (Fe-CO) stretching mode is seen at
484 cm-1, with its corresponding ν(C-O) mode occurring at 1935 cm-1; i.e., a new Fe-C-O
conformer is formed upon OMP binding. It should be recalled that, while the Phe87
residue of the WT protein (with NPG substrate bound) lies almost parallel to the heme
plane (Figure 4.3.3), this residue assumes a nearly perpendicular orientation with respect
to the heme plane for the A82F mutant; i.e., presumably the newly observed conformer
(with the 484/1935 cm-1 pair of Fe-C-O modes) results from this reorientation of the
Phe87 fragment.
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In the case of the F87V BM3 mutant, it is interesting to note that while the ferric
substrate-free heme domain showed no evidence for heterogeneity, there are two ν(FeCO) stretching modes seen in the spectrum of the CO adduct, observed at 470 and 480
cm-1, with the corresponding ν(C-O) modes occurring at 1947 cm-1 and 1936 cm-1,
respectively (Figure 4.3.6, trace C). Based on relative intensities, the ν(C-O) mode at
1947 cm-1 corresponds to the 470 cm-1 (Fe-CO) mode and the 1936 cm-1 feature is
correlated with the 480 cm-1 (Fe-CO) mode. Obviously, this behavior is consistent with
the well-documented inverse wavenumber relationship. As the less bulky valine was
introduced to replace the phenylalanine sidechain, a more open distal pocket provides an
environment with greater opportunities for conformational flexibility of the Fe-C-O
fragment. The effect of OMP binding on the F87V mutant, now devoid of the intrusive
phenyl group, has a rather dramatic effect on the Fe-CO linkage, leading to a high
population of a fragment participating in a relatively strong H-bonding interaction, as
evidenced by the 485/1933 cm-1 pair of bands, an interaction presumably associated with
the OMP substrate.
Given this apparent key role for the F87V mutation in regulating active site
environment, it is not surprising that the vibrational mode patterns for the Fe-C-O
fragment for the double mutant are virtually identical to those observed for the F87V
mutant (within a couple wavenumbers and having quite similar relative intensities). The
most likely candidates for a strongly polar group associated with substrate binding are the
methyl ether substituent of the pyridinyl frament or, perhaps less likely, the S=O group,
either of which is likely to associate with a distal pocket water molecule, polarizing it to
serve as an effective H-bond donor.
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The wavenumbers of the ν(Fe-C) and ν(C-O) stretching modes for the ferrous-CO
adducts of all of the P450 BM3 heme domain variants studied here, including the
substrate-free and OMP-bound forms, are collated in Table 4.3.2. The resulting plot of
the ν(Fe-C) vs ν(C-O) values, (Figure 4.3.7) yields the expected inverse correlation.140 In
Figure 4.3.7, the correlation line for nitric oxide synthase, NOS, (green line) 141,142 is
displaced above the P450 line, owing to correspondingly higher ν(Fe-C) stretching modes
that result from the fact that a proximal pocket tryptophan residue provides an H-bond
donor fragment to the proximal thiolate ligand of NOS, weakening the Fe-S linkage.
Below this line lies the line for P450cam (blue line),59,143,144 which possesses a more
strongly electron donating thiolate proximal ligand, leading to relatively high ν(Fe-S)
stretching modes occurring near 350-355 cm-1.39 The data points for the P450 BM3 heme
domain and mutants yield a line close to that of P450cam (red line), but with a slightly
greater slope, reflecting a wider variation in distal pocket polarity; this observation is
consistent with the higher polarity of the OMP substrate compared to the collection of
less polar substrates in the study of P450cam.
In conclusion, the resonance Raman data presented here show that the binding of
OMP causes a substantial increase in distal heme-pocket polarity in the BM3 F87V,
A82F and F87V/A82F mutant heme domains. The addition of OMP has no effect on the
Fe-C-O fragment in the wild-type P450 BM3 heme domain, confirming earlier results
indicating that OMP does not enter the heme pocket.120 The F87V mutation has a strong
impact on the modes of the Fe-C-O fragment, an observation consistent with the
structural changes enabled by this mutation within the heme distal pocket. In general, the
data acquired here highlight the ability of these mutations to effectively influence protein
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structure and so to alter the substrate selectivity of BM3, as demonstrated by their
introducing catalytic activity towards OMP and related PPI drugs.120, 118 These rR studies
provide important new structural insights into BM3 mutants that have gained novel
functions in PPI drug metabolism through changes to P450 conformational state and
active site organization produced through introduction of the A82F and F87V mutations,
respectively. These BM3 mutants catalyze the 5-hydroxylation of OMP (and oxidation of
other PPI drugs), generating the same metabolite produced by human P450 2C19, as well
as other human P450-type metabolites (e.g. from rabeprazole and lansoprazole) that
should make these drug metabolites more readily available as standards for tests required
for FDA compliance.
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Table 4.3.2 The frequencies of ν(Fe-C) and ν(C-O) stretching modes for P450 BM3
proteins. The numbers in the column represents points in Figure 4.3.7.
P450 BM3

 (Fe-C) cm-1

(C-O) cm-1

1

wild type substrate-free

471

1943

2

wild type + OMP

471

1943

3

A82F substrate-free

472

1947

4

A82F + OMP

472

1947

5

A82F + OMP

484

1935

6

F87V substrate-free

470

1947

7

F87V substrate-free

480

1936

8

F87V+ OMP

474

1945

9

F87V+ OMP

485

1933

10

A82F/F87V substrate-free

473

1945

11

A82F/F87V substrate-free

483

1933

12

A82F/F87V + OMP

475

1945

13

A82F/F87V + OMP

483

1934

CYP101
14

substrate-free

464

1963

15

+ norcamphor

473

1947

16

+ adamantanone

474

1942

17

+ camphoroquione

476

1941

18

+ fenchone

480

1945

19

+ camphor

481

1940

20

+ tetramethylcyclohexanone

485

1934

NOS
21

nNOS Substrate-free

487

1949

22

nNOS Substrate-free

501

1930

23

nNOS + Arg

503

1929

24

nNOS + OH-Arg

502

1928

25

NOSFL substrate-free

487

1945
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Figure 4.3.7. Diagrams showing an inverse correlation for P450 BM3 (wild type and
mutants), P450cam and NOS in substrate free and substrate bound form. The numbers
represent proteins listed in Table 4.3.2. The red triangles show points for P450 BM3 (red
line), the blue diamonds for P450cam (blue line), and green squares for NOS (green line).
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Chapter 5 Resonance Raman investigations on cytochromes P450 peroxygenase: Ole
T (CYP152L1) and P450 Staph (CYP152L2)

5.1 Introduction

While the majority of known cytochromes P450 use NAD(P)H-dependent
reductase systems and the O2-bound intermediate to eventually produce Compound I,
several P450s have evolved to exploit the so-called “peroxide-shunt” pathway, where
reaction of the ferric heme with H2O2 directly produces “Compound 0”, which rapidly
converts to Compound I, a mechanism which bypasses any need for partner reductases,
prompting the designation of peroxygenases for these P450s, the mechanism is shown in
Figure 5.1.1 (grey arrows).145 In contrast to other monooxygenase P450s that use the
oxygen as oxidizing agent (double-headed arrow in Figure 5.1.1), these peroxygenases
utilize H2O2 to facilitate substrate oxidation to replace the need for solubilized oxygen
and the complex reductase system. Needless to say, this efficient peroxide activation
route has attracted great interest for biotechnological purpose.146
Two of these, one from Bacillus subtilis, CYP152A1 (P450BSβ), and the other,
from Sphingomonas paucimobilis, CYP152B1 (P450SPα), employ H2O2 to efficiently
catalyze the hydroxylation of long chain fatty acids (FAs).145, 147 While P450SPα catalysis
is highly specific, with nearly exclusive hydroxylation at the α position, P450BSβ
catalyzes hydroxylations at both the α (40%) and β (60%) positions.145 Another
peroxygenase, recently isolated from Jeotgalicoccus and characterized by Rude et al,148 is
41% identical in sequence to P450BSβ and 37% to P450SPα. The authors designated this
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enzyme as a CYP152 P450 family member (i.e., CYP152L1), whose commonly used
name is Ole T. While reasonably close in sequence with the other CYP152 members
mentioned above, Ole T displays a much different catalytic activity. Like P450SPα and
P450BSβ, Ole T also has high affinity for long chain FAs; however, instead of catalyzing
hydroxylations at α and β positions, Ole T catalyzes a remarkable transformation of FAs,
converting them into linear and branched chain terminal alkenes involving a C-Cα bond
cleavage process, as shown in Figure 5.1.2.149

Figure 5.1.1 The catalytic mechanism for Ole T and general P450.149
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Figure 5.1.2 The C-C cleavage reaction catalyzed by Ole T.

In order to better understand the stark differences in catalytic activities, direct
comparisons have been made for crystal structures of Ole T,149 and P450BSβ,145 revealing
a similar substrate binding mode in which the fatty acid carboxylate is tethered via
electrostatic interactions to an active site arginine (Arg245). A most interesting difference
in the two structures is the replacement of Q85 in the P450BSβ enzyme with a potentially
H-bonding H85 in the case of Ole T. Attempts to relate the effects of this residue
replacement to possible mechanistic differences have been made. However, our
collaborator, Professor Thomas Makris and his group, have shown that introducing the
H85Q mutation into Ole T does not diminish conversion of C20 FA to nonadecene. These
and other spectroscopic and kinetic studies have led Professor Makris to consider other
possible mechanisms.150 In presence of per-deuterated eicosanoic acid (C20D FA) with
excess H2O2, a Compound I species is accumulated to a high level with its optical
spectroscopic characters being similar to those observed spectra (Soret band 370nm and
an additional band at 690nm).52 In a parallel experiment, the protiated native substrate
bound Ole T failed to permit accumulation of Compound I. Such an apparent kinetic
isotope effect strongly suggests that a hydride removal from C position initiates fatty
acid decarboxylation performed by Compound I.149 The newly proposed mechanism is
shown in Figure 5.1.3, following by H abstraction from C20 fatty acid by Compound I, a

106
substrate radical and a Fe (IV) Compound II species are generated, either a substrate
biradical or carboncation is produced involving a single electron transfer to Compound II,
which can be further rearranged to generate the alkene products.151

Figure 5.1.3. Proposed mechanism for Ole T decarboxylation reaction catalyzed by P450
Compound I.

The other CYP152 family enzyme, CYP152L2 from Staphylococcus massiliensis,
named as P450 staph (abbreviated as CYP-SA), is a close orthologue to the P450 Ole T
CYP152L1 with 61% identity shared. Both enzymes have highly similar properties and
perform highly similar reactions. Although here are a couple of differences on the protein
surface, the active site is very similar. The one main difference is that CYP-SA is much
more stable than Ole T, this is a huge advantage as Ole T has a big precipitation/P420
issue upon thawing/freezing and reduction process, thus trapping the unstable
intermediate on this analogy could be extremely informative on both enzymes.
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The general purpose of this project is to use resonance Raman spectroscopy to
track how well the O2 driven pathway works with peroxygenase enzymes, as there is
always a large interest in seeing if Ole T can turn over with O2 and electrons, which could
be much easier for biofuel generation in organisms since it is difficult to leverage H2O2 in
cells. Thus, rR experiments are planned on Ole T (CYP152L1) and CYP-SA
(CYP152L2) in presence of per-deuterated eicosanoic acid substrate, which will be quite
useful in providing information, such as potential heme macrocycle distortions and
reorientation of peripheral substituents, it will be also interesting to investigate how the
substrate position affects the disposition of the diatomic ligand, including the Fe-CO and
Fe-O-O fragments, which can lead to a better understanding of both the Fe-S strength in
the proximal side and the H-bonding environment in distal pocket.
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5.2 Experimental

5.2.1 Sample preparation

The following samples were kindly provided by our collaborator, Dr. Thomas
Makris from the University of South Carolina University, including: 1) 290 M Ole T, in
clean ES complex with deuterated eicosanoic acid (C20D FA) in 250 mM phosphate
buffer (pH=7.5) with 250mM NaCl, prepared in H2O. 2) 200 M CYP-SA in 200 mM
phosphate buffer (pH=7.5), containing 30% purified glycerol (v/v).
Some of P450s and/or fatty acid substrate precipitates out of solution upon
thawing, and those samples were centrifuged to eliminate the precipitations before use.
Ferric samples were prepared by directly transfering 50uL of protein to an NMR tube.
The ferrous samples were prepared by adding degassed sodium dithionate solution into
the argon equilibrated protein samples, where monitoring the 642nm Q band in Uv-vis
spectra, until it completely disappears. This is all done at room temperature.
5.2.1.1 Ferrous CO samples for rR measurement

The ferrous CO adducts of both Ole T and CYP-SA enzymes were prepared in
exactly the same way with the presence of methyl viologen to facilitate reduction (molar
ratio of protein to MeV is 5:1). Specifically, 50L of CYP-SA protein was placed in
NMR tube (WG-5 Economy, Wilmad) which was sealed with a rubber septum (Sigma
Aldrich, Milwaukee, WI). After degassing with CO gas for 15 minutes, the proteins were
reduced by injecting a stoichiometric amount of sodium dithionite solution, which is
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prepared freshly in degassed buffer. Then the sample was further equilibrated with CO
gas by bubbling for an additional 10 mintues to ensure full converstion.
5.2.1.2 Ferrous dioxygen adduct preparation

Oxy samples were prepared by using the vaccum line in our lab, on which the
NMR tube could be easisly connected with sealed connection parts. Starting with the
ferric substrate-bound samples, vaccum was applied to the tube first and then refilling
with Ar gas, repeating this process for several times to ensure there is no presence of
oxygen. Sodium dithionite solution was titrated to the enzyme through a long needle
attached to a syringe, until the 642 nm band disappeared in the Q region of Uv-vis
spectra. Again, the enzyme is reduced in presence of Methyl Viologen. Then, reduced
CYP-SA sample tubes were transferred to a dry ice-ethanol bath held at -20°C to be
cooled down for 1 minute. Oxy-ferrous complexes were made by bubbling 16O2 or 18O2
for 10 seconds, followed by rapid freezing in liquid N2 to avoid auto-oxidation.
However, lots of efforts were taken on making oxy Ole T under different
conditions; i.e., 16O2 or 18O2 gas was bubbled into the reduced Ole T at different
temperatures to find the suitable conditions of oxy complex formation, including -20°C, 15°C, -12°C, -10°C and 4°C, with a mixing time ranging from 10-20s. The procedure of
making oxy compound is exactly same as state above.
5.2.2 Resonance Raman Measurement

The spectra of ferric samples was obtained using a 406.7nm excitation line and
the spectra of ferrous and oxy samples were measured using 413.1nm line, both lines
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being provided by a Kr+ laser (Coherent Innova Sabre Ion Laser). And the spectra of the
ferrous CO sample, were acquired with the 441.6 nm excitation line from a He-Cd laser
(IK Series He-Cd laser, Kimmon Koha CO., Ltd.). The RR spectra of all samples were
measured using a Spex 1269 spectrometer equipped with a Spec-10 LN liquid nitrogencooled detector (Princeton Instruments, NJ). The slit width was 150 μm, and the laser
power for ferric sample was kept around 10mW, whereas for the ferrous CO and oxy
complex, the power was adjusted to ~1 mW. All samples were measured in a spinning
NMR tube and a cylindrical focusing lens to avoid local heating and protein degradation.
It is emphasized that, the oxy adducts were measured at 77K, in a home-designed glass
dewer filled with liquid nitrogen. Spectra were calibrated with fenchone and processed
with Gram/32 AI software (Galactic Industries, Salem, NH).

5.3 Results and Discussion

5.3.1 Results of ferric Ole T protein with deuterated eicosanoic acid (C20D fatty
acid)

The high-frequency rR spectrum of substrate-free (SF) Ole T is shown in Figure
5.3.1 (trace A). The peak occurs at 1373 cm-1, assigned as the oxidation state marker
band, 4, indicating the protein is in ferric state. The spin state markers 3 and 2 mode
occurs at 1502 and 1581 cm-1, confirming the presence of a pure six-coordinated low spin
(6cLS) form. The modes observed at 1619 and 1628 cm-1 were assigned to two vinyl
stretching vibrations. Addition of the substrate, C20D fatty acid, to the enzyme caused a
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large degree of conversion from LS to HS component, as reflected by the relatively
higher intensity of high spin 3 (1488 cm-1) band than the low spin 2 mode (1502 cm-1);
the HS component is estimated to be 70% by employing the value of IHS/ILS determined
to be 1.24.101 This spin state mixture is also reflected by alterations in the 2 and ν10
bands; i.e., the 2 bands occur at 1565 cm-1 and 1637 cm-1. However, it is difficult to
estimate the mix spin state mixture from the 10 band since the high spin state 10 band
usually overlaps with the vinyl stretching mode which occurs at 1623 cm-1.

Figure 5.3.1 The high frequency rR spectra of Ferric Ole T protein. (A) substrate-free
Ole T (B) C20D-bound Ole T. Spectra were normalized to the ν4 mode at 1374 cm-1.
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The low-frequency rR spectrum of SF Ole T is shown in Figure 5.3.2 (trace A).
The assigned heme skeletal modes are ν7 (676cm-1), ν15 (752 cm-1) and ν8 (348 cm-1). A
shoulder of ν7, appearing at 695 cm-1, can be allocated to 20. According to the complete
assignments of other heme proteins, including globins and Cytochromes P450, the bands
observed in the region of 365-380 cm-1 are typically assigned to the bending modes of the
heme propionate groups,125 though they are more properly interpreted as heme
deformation modes that involve significant contributions from the propionate bending
coordinates as well as δ (Cβ-CH3) motions: herein, the bands occuring at 372 and 382 cm1

are assigned as heme propionate bending modes. Likewise, bands appearing between

400-440 cm-1 are assigned to “vinyl bending” modes,128 with frequencies observed at 414
and 426 cm-1, values which are in good agreement with the observations of two vinyl
stretching modes observed in the high frequency region, as mentioned earlier.
Binding of the C20D fatty acid substrate does not induce a significant change in
the heme skeletal vibrations, 8, 15 and 7, at 348 cm-1, 752 cm-1, 676 cm-1 respectively,
in the low-frequency region, as shown in Figure 5.3.2 (trace B). However, it can be seen
that one propionate bending mode occurs at lower frequency (372 cm-1) decreased
relative intensity compared to the other higher frequency bending mode. It is generally
agreed that this lower frequency propionate bending mode is associated with the greater
hydrogen-bonding network between the propionate and surrounding amino acid residue.
One possible explanation for this is the H-bond network is disrupted and thus showing
the deactivation of one propionate bending mode or, more likely that both propionates
have similar environments.
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Figure 5.3.2 The low frequency rR spectra of Ferric Ole T protein. (A) substrate-free Ole
T (B) C20D-bound Ole T. Spectra were normalized to the ν7 mode at 676 cm-1.

5.3.2 Results of ferric CYP-SA protein with deuterated eicosanoic acid (C20D fatty
acid)

The high-frequency RR spectra of ferric state P450-SA is shown in Figure 5.3.3,
noting that the band appearing at 1468 cm-1 is attributable to glycerol. The ν4 mode was
seen at 1373 cm-1, which indicates the sample is in ferric state. Furthermore, the spin state
marker, ν3 mode at 1504 cm-1 shows the presence of 6cLS state. There is also a relatively
higher intensity 5cHS component observed (ν3 at 1490 cm-1). This spin state mixture is
also reflected by alterations in the ν 2 and ν10 bands; i.e., the ν 2 bands occur at 1571 cm-1
and 1584cm-1, which the ν 10 bands occur at 1632 and 1642 cm-1. It is also important to
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notice two vinyl stretching mode occurs at 1623 cm-1 and 1632 cm-1 (the last being
overlapped with ν10).
The low-frequency region of rR spectra of CYP-SA is shown in Figure 5.3.4. The
assigned heme skeletal modes are ν7 (675cm-1), ν15 (754 cm-1) and ν8 (345 cm-1). A strong
shoulder of ν7 appearing at 694 cm-1 can be allocated to 20. According to the complete
assignments of other heme proteins, including globins and Cytochromes P450, the bands
observed at 365 and 380 cm-1 are assigned to the bending modes of the heme propionate
groups,125 Similarly, bands appearing between 400-440 cm-1 are assigned to “vinyl
bending” modes, which occurs at 412 and 425 cm-1. It is interesting to note that in this
C20A bound sample, the intensity of heme out-of-plane modes are relatively strong; i.e.,
7 and 12 occurs at 322 cm-1 and 492 cm-1, which implies a greater oop distortion of
heme macrocycle compared to Ole T.152 Collectively, it can be concluded that CYP-SA
heme cofactor possesses a ruffled, highly distorted posture reflected by relatively intense
oop modes seen in rR spectra.
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Figure 5.3.3 High-frequency rR spectra of P450-SA. Spectra were measured at room
temperature with excitation line at 406.7 nm.

Figure 5.3.4 Low-frequency rR spectra of P450-SA. Spectra were measured at room
temperature with excitation line at 406.7 nm.
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5.3.3 Ferrous-CO samples of Ole T and CYP-SA characterized by resonance Raman
Spectroscopy

One of the most important factors that control the reactivity of Cytochromes P450
is the strength of linkage between the heme iron and the proximal cysteine thiolate.
Interrogation of the ferrous CO adducts of heme proteins using rR has been proven to be
an effective probe of this linkage, including the proximal active site environment,
especially H-bonding interactions with surrounding amino acid residues. Basically, the
strength of Fe-S ligand can be reflected from trans-axial exogenous ligand with
measurable changes in the internal modes for the Fe-CO fragment, which depend on
extent of dπ (Fe) to CO (π*) backbonding donation. In order to better understand the
structural factors involved in CYP152 family, the rR spectroscopy is performed on
ferrous CO CYP152 complexes.
The rR spectra of ferrous CO Ole T substrate-free complex is shown in Figure
5.3.5, trace A, with the left panel showing the low frequency spectra, indicating the
presence of two Fe-CO fragments, with the (Fe-C) frequencies observed at 467 and 479
cm-1. The presence of two conformers is confirmed by the observation of the two
corresponding (C-O) modes being observed at higher frequency at 1939 and 1957 cm-1
(Figure 5.3.5, trace A right panel). In contrast, binding of a long chain C20D fatty acids
to Ole T with its polar carboxylate group lying close to the heme iron, gives rise to only
one distinct Fe-C feature, which appears at 476 cm-1, with its correlated C-O stretching
mode occurring at 1941 cm-1 (Figure 5.3.5, trace B). It can be suggested that a more
constrained distal pocket is formed as the bulky long chain fatty acid is anchored into the
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active site, allowing less space for Fe-CO movement, consistent with only one
conformer. Similarly, only one Fe-CO stretching mode (479 cm-1) is detected for the
C20D bound CYP-SA CO complex, with the associated (C-O) mode seen at 1949 cm-1
(Figure 5.3.6).
To gain more insight into the electrostatic and H-bonding effects in the active site
of the enzyme, a plot of the inverse backbonding correlation line between (Fe-C) and
(C-O) frequencies is shown in Figure 5.3.7. The data points for Ole T and CYP-SA
samples are shown in yellow and purple dots, respectively, along with similar plots for
other previously reported cytochrome P450cam (in blue line),143,59, 139,139 mammalian
nitric oxide synthase (NOS) in grey lines142,141 and the histidine ligated myoglobin (Mb)
variants with differing distal residues (orange line).153,154,155,156 The values for all the
points are listed in Table 5.3.1. The data points for these myoglobin variants are highly
informative; as is well-known, the His64 residue in wild-type Mb provides a weak Hbond donor to the Fe-CO fragment, and replacing the His64 with a more hydrophobic
residue can lead to a downshift data points along the backbonding line. However,
mutation of His64 to a stronger H-bond donor residue can shift the point up (left).157
Thus, the increased polarization effect in distal pocket can be reflected by the position of
data points. Compared with the histidine ligated myoglobin variants, P450cam possesses
a stronger donor thiolate ligand from a cysteine side chain, which is expected to decrease
v(Fe-C) frequency via sigma competition, thus showing a backbonding line below the
Mb line. Consistent with the trend, the NOS enzymes, which have a proximal cysteine
residue, exhibit a line between these two lines owing to the fact that they possess a
proximal H-bond donor with tryptophan residues, this lead to a lowered thiolate donor
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strength, thus exhibiting a separate line between P450cam and Mb backbonding lines.
Considering all the data points for CYP152L enzymes herein, it is important to notice all
these data points fit very well on the correlation line for P450cam, showing a similar Fe-S
strength and proximal environment. On the other hand, the C20D bound samples yield a
higher position along the line, suggesting the increased polarity in the distal pocket,
which can be well postulated that the H-bonding interaction is enhanced by the
introduction of the polar carboxyl group of the substrate.

Figure 5.3.5 rR spectra of Ole T CO complex. Spectra were measured at room
temperature with excitation line at 441.6 nm. Left panel shows Low-frequency region,
middle panel presents high frequency, and right panel shows the region where the C-O
stretching mode occurs.
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Figure 5.3.6 rR spectra of C20D fatty acid bound CYP-SA complex. Spectra were
measured at room temperature with excitation line at 441.6 nm. Left panel shows Lowfrequency region, middle panel presents high frequency, and right panel shows the region
where the C-O stretching mode occurs.

Figure 5.3.7 backbonding correlations of FeCO adducts in different heme proteins which
yielding various axial ligands: blue line – thiolate ligated P450cam, grey line – thiolated
ligated with Tryptophan backbone H bond NOS, orange line- myoglobin variants with
differing distal residues. The data points for Ole T CO complex are shown in yellow dots
while the CYP-SA CO data point is shown in purple.
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Table 5.3.1 values of all the points for plotting Figure 5.3.5 are listed below. References
are cited in the content.
P450 cam
substrate-free
+ norcamphor
+ adamantanone
+ camphoroquione
+ fenchone
+ camphor
+tetramethylcyclohexanone
Mb
WTSW
WTSW pH=8.4
WTSW pH=7.0
WTSW pH=2.6
WTh
WTp
H64Qh
H64Gh
H64ASW
H64VSW
H64ISW
H64LSW
V68Th
V68Np
F46VSW
L29F/H64QSW
H64V/V68Tp
nNOS
substrate-free
substrate-free
+ Arg
+ HO-Arg
iNOS substrate-free
iNOS + Arg
CYP152 enzyme
Ole T substrate free
Ole T substrate free
Ole T C20D bound
CYP-SA C20D bound

(C-O) cm-1
1963
1947
1942
1941
1945
1940
1934

(Fe-C) cm-1
464
473
474
476
480
481
485

1937
1944
1947
1966
1941
1944
1945
1965
1966
1967
1968
1965
1961
1922
1967
1938
1984

515
512
507
489
508
508
507
492
490
488
490
490
491
526
489
513
479

1949
1930
1929
1928
1945
1906

487
501
503
502
487
512

1957
1939
1941
1949

467
479
476
479
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5.3.4 rR investigations on ferrous-dioxygen adduct of Ole T and CYP-SA

As discussed earlier in this dissertation, the rR technique applied to oxy
intermediates of CYP17 had shown the impressive potential to detect the subtle active
site structure perturbation especially the H-bond interactions with the Fe-OO fragment.91
Specifically, H-bonding to the proximal O of the Fe-OP-OT fragment causes decrease of
Fe-O stretching mode, in this case, the H-OP interaction is expected to inhibit bond
cleavage and prolong the lifetime of the peroxo intermediate, allowing nucleophilic
attack on susceptible substrates leading to the C-C bond cleavage lyase reaction.158 Hbonding to the terminal O will shift up the Fe-O stretching mode, and the H-OT
interaction promotes O-O bond protonation and cleavage, finally yielding Compound I
intermediate, which effective mediate hydroxylation reactions.159 Needless to say, such a
powerful technique is able to detect subtle structure variations that can dramatically
impact enzyme function.
The original plan is to prepare and trap the ferrous dioxygen adducts of Ole T and
characterize it and following intermediates in the P450 enzyme cycle with rR
spectroscopy. However, although a lot of effort was spent trying to prepare and trapp the
dioxygen adduct, under different conditions, as summarized in section 5.2.1.2. Since all
the samples are freezing immediately after mixing with oxygen, the complex formation
can only be examined by rR spectroscopy which the samples could be measured in liquid
nitrogen temperature using home design setup in our lab. After long rR spectral
acquisition time on these frozen samples, there was no evidence obtained for dioxygen
adduct formation. These disappointing results led us to reconsider various possibilities for
the failure to generate fragile oxy samples. The first step of the cycle begins with the
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substrate-bound ferric samples, where rR spectra is earlier shown in Figure 5.3.1. The
presence of 70% HS form in this sample eliminates our worry about whether this organic
substrate could reach sufficient concentrations to sheathe the highly concentrated enzyme
(200 M), However, it is important to notice that these samples quite readily generate
precipitation due to the excess amount of organic fatty acid substrate present. So the
reduction process on substrate-bound form were carefully checked before dioxygen
bubbling. The collected rR data for ferrous form is shown in Figure 5.3.8, the intense
sharp peak 4 in high frequency region occurs at 1358 cm-1, indicating the P420 form
formation (inactive form of enzyme which the CO adduct exhibits a Soret band at
420nm); i.e., the ferrous P450 form typically has a 4 occuring at 1347cm-1. A similar
pattern is seen in the camphor bound CYP101 P420, the 4 mode shifts from 1372 to
1361 cm-1 upon the reduction.127 Under this situation with quick P420 formation upon
reduction, trapping oxygen adduct would be difficult.

Figure 5.3.8 rR spectra of ferrous substrate-free and C20D bound enzyme. Left panel
shows low frequency and right panel shows the high frequency region.
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While the other CYP152 enzyme, CYP-SA, shares highly similar active site
structure with Ole T, it is much more stable than Ole T, without any P420 conversion and
substrate precipitation issues. Thus, the study the dioxygen adduct of CYP-SA is an
alternative way to gain useful information. The 413.1 nm excitation line from Krypton
laser is selected as the closest line to the Soret band of oxy CYP-SA (428 nm). Due to the
low S/N of these frozen samples, the modes of Fe-O-O fragment were identified using
difference traces of O2 isotope, the resultant spectra being seen in Figure 5.3.9. As seen in
trace C, an (Fe-16O) occurs at 513 cm-1 with the (Fe-18O) seen at 486 cm-1, which is
shifted down by 27 cm-1 (calculated to be 25cm-1). Usually, the frequency of  (Fe-O) can
be modulated by direct H-bonding interactions between the bound oxygen and
neighboring residues. It is interesting to notice that the frequency of Fe-O is unusually
low, compared with other Cytochrome P450s whose frequencies typically occur in the
region 526-542 cm-1.91, 63, 109 It can be postulated that the significant reduction in the 
(Fe-O) frequency is caused by a relative strong distal hydrogen bonding to the proximal
oxygen of Fe-OP-OT fragment, this could be consistent with a lowering of the tendency
for the O-O bond cleavage, allowing the enzyme to utilize a peroxo intermediate as the
oxidizing species. One puzzling observation is that, there is no appreciable O-O
stretching mode detected in the higher frequency region (1000-1700 cm-1). It is believed
that the distal interactions can alter the mechanism of enhancement by changing the
energy level of Fe-O2 molecular orbital, thus the silence of O-O stretching mode could be
either attributed to the ruffled heme plane, or it can be suggested that the Fe-O-O unit is
highly bent, showing steric interactions between Fe-OO fragment and steric bulk of
substrate/residues of distal pocket.
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Figure 5.3.9 rR spectra of P450-SA oxy complex in mid-frequency. Spectra were
measured at liquid nitrogen temperature with excitation line at 413.1 nm. (A) CYP-SA
16
O2 complex, (B) CYP-SA 18O2 complex, (C) difference spectra: trace A-trace B.

In summary, the results presented here provide a general idea of the effect of the
C20D fatty acid on the active site structure, including the spin state conversion and vinyl
and changes of protein interaction with vinyl and propionate groups of heme. The rR data
of ferric OleT indicates the introduction of bulky fatty acid substrates cause the
reorientation of propionate group, while the CYP-SA C20D bound data strongly
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suggesting a ruffled, highly distorted heme cofactor. Both of the CO complexes of Ole T
and CYP-SA indicate a strong Fe-S linkage like P450cam, while the presence of the
C20D fatty acid substrates bring the additional H-bonding in the distal pocket. Though
not yet successful in trapping the Ole T dioxygen complex, the ferrous dioxygen adduct
of the Ole T analogue, CYP-SA, seems to suggest the presence of a strong hydrogen
bond donor to the proximal oxygen of Fe-OP-OT fragment, suggesting a mechanism that
could involve a stabilized peroxo species is the oxidizing species.
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Chapter 6 Conclusion

Heme proteins play an important role in many biological processes, they all
recruit a heme cofactor into the enzyme active site to display a remarkably diverse range
of chemical activity. These include the electron transport proteins, oxygen transport
proteins, heme sensor proteins and the most interesting, catalytic proteins, which can
effect quite remarkable chemical transformations under physiological conditions. Among
all these heme containing enzymes, cytochromes P450 and peroxidases are of great
interest for study in our lab. Within the catalytic cycles of these proteins, highly reactive
intermediates are generated; these actually dictate the chemical reactivity, but historically
it has proven very difficult to structurally characterize these fleeting species. Fortunately,
resonance Raman spectroscopy has emerged as a very effective technique to study
structural changes of these crucial intermediates.
Cytochromes P450 exist in many organisms throughout the biosphere,
from bacteria to humans. However, most of the significant progress in understanding the
mechanisms of P450s was made by studying the bacteria P450s, as they are soluble and
easily isolated compared to the mammalian P450s. Chapter 2 describes the methods used
for the expression and purification of a bacteria P450, CYP101A1, which hydroxylates
the substrate, camphor. In this work, CYP101 was used as a vehicle to gain important
experience in protein expression and purification as well as providing a relatively stable
enzyme to gain valuable expertise in acquiring resonance Raman spectral data. Indeed,
this enzyme has served as the paradigm of cytochrome P450 structure and function
during the past 5 decades.
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Cytochrome P450 is a broad class of heme monooxygenase enzymes, which
catalyze various oxidative transformations. Mammalian P450s can be classified into two
main sub-classes, one is involved with drug metabolism and the other comprises enzymes
that participate in steroidogenic processes. Chapter 3 of this dissertation focuses on one
of these steroidogenic P450s, CYP17A1, which not only catalyzes hydroxylation
reactions, but also promotes C-C bond cleavage reactions; i.e., lyase reactions.
Cytochrome b5 is known to be a key regulator of this latter activity by a mechanism that
is not well understood. Here, nanodisc technology is used to prepare functional dyads of
these proteins and resonance Raman spectroscopy is effectively employed to structurally
characterize protein-protein interactions. Results of careful functional studies show no
impact of (redox inactive) Mn b5 on the lyase reaction, indicating mainly an electron
transfer role for cytochrome b5 in the lyase reaction. While resonance Raman
spectroscopic studies showed that Mn b5 binding does not affect the heme skeletal modes,
they do reveal a slight increase the strength of the Fe-S bond, as well as a weakening of
the Fe-O bond of OH-PROG bound CYP17, while that of the enzyme complex with the
lyase substrate, OH-PREG, remains unaffected.
Chapters 4 and 5, focus on cytochromes P450 that are attracting growing attention
from an industrial prospective, especially the exploring of protein engineering as an
effective approach for important applications in biotechnology. The bacterial fusion
enzyme, P450 BM3 (CYP102A1), which includes a fused reductase domain, is a good
target of exploration for biotechnologically useful purposes, especially its A82F, F87V
and the double mutant, which enhance the affinity for the human P450 drug metabolite,
omeprazole (OMP). Here again, as in Chapter 3, rR spectroscopy was useful in showing
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OMP does not bind in the active site of WT BM3, does bind and cause rR-detected
structural changes within the active sites of the A82F, F87V and double mutations of
P450 BM3.
Chapter 5 describes initial studies conducted to investigate P450 peroxygenase
enzymes [CYP152L1 (Ole T) and CYP152L2 (CYP-SA)], both of which are able to
convert fatty acids to terminal alkenes. They use a “peroxide-shunt” pathway, generating
crucial intermediates via reaction of the ferric heme with H2O2, following a mechanism
which bypasses any need for partner reductases, an attractive activation route for
biotechnological applications. The acquired rR data documented a 70% HS component
upon binding of the substrates, also showing that the introduction of bulky fatty acid
substrates causes the reorientation of a propionate group on Ole T enzyme, while
inducing a ruffled, highly distorted heme cofactor in the CYP-SA C20D bound enzyme.
Spectra of the CO complexes of Ole T and CYP-SA indicate a strong Fe-S linkage,
comparable to that of P450cam. In future studies it will also be of great interest to
document any differences in the key Fe-O-O fragments of the “precursor” to the
Compound I intermediate. Though unsuccessful in trapping the Ole T dioxygen complex,
preliminary studies of the ferrous dioxygen adduct of the Ole T analogue, CYP-SA,
provides evidence for a strong hydrogen bond to the proximal oxygen of Fe-OP-OT
fragment, an observation that is consistent with a stabilized peroxo intermediate.
Overall, the extensively rR studies performed here on quite different heme
proteins demonstrate how useful such studies can be in revealing how enzyme reactivity
can be profoundly affected by subtle structural changes.
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Appendix: Analysis of Heme Iron Coordination in DGCR8: The Heme-Binding

Portions of this chapter have appeared in the paper:
Girvan, H. M,; Bradley, J. M.; Cheesman M. R.; Kincaid, J. R,; Liu, Y.; Czarnecki,
K,; Fisher, K,; Leys, D,; Rigby, S. E. J,; Munro, A. M,; “Analysis of Heme Iron Coordination
in DGCR8: The Heme-Binding Component of the Microprocessor Complex” Biochemistry,
2016, 55, 5073–5083
1. Background of DGCR8

This is a small project which cooperating with Dr. Munro’s group, which aims to
use resonance Raman spectroscopy in our laboratory as an assist tool to help identifying
the coordination environment of DGCR8. The work was publish in ACS Journal of
Biochemistry.72
Micro RNAs are a small non-coding RNAs which are only ~22 nucleotides which
plays a significant role in the regulation of cellular function in animals and plants and in
certain viruses. They can prevent translation process by binding with messenger RNA.160
As shown in Figure A1, mature miRNA needs to be processed from primary miRNA by a
series of cleavage steps to reach the activation in gene regulation. Firstly, a pri-miRNA is
cleaved in the nucleus into an intermediate called the precursor miRNA by the RNase III
enzyme Drosha, this process will not happen with the assistance of DGCR8. Then the
precursor miRNA was transported to cytoplasm and finish the further cleavage steps with
the help of different types of enzymes.161
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Figure A1. Process of generating mature microRNA.

Earlier studies reported spectroscopic data consistent with bis-cysteine ligation of
the heme iron and suggested that a single heme was coordinated by Cys352 side chains
from both DGCR8 proteins in a dimer.162
DGCR8 is the first example of a heme binding protein with two endogenous
cysteine side chains serving as axial ligands. This special the heme environment of
DGCR8 attracts more interest and thus resonance Raman and Uv-vis spectroscopy are
effective tools to probe the structure in different forms.
2. Uv-vis spectroscopic analysis of DGCR8.

The Uv-vis spectra of ferric state of DGCR8 is shown in Figure A2 (red line), it is
showing a hyperporphyrin spectrum with the main soret peak at 450 nm and the second
feature at 367 nm. In the visible region, the ferric heme exhibits a broad absorption
feature with a peak at 557 nm and a shoulder at 586 nm. This is consisted with the
spectrum of a ferric bis-Cys heme ligated model complex.
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The reduced DGCR8 is shown in green lines with the Soret band at 427 nm and
531, 559 nm band in visible region. Dawson’s group conducted a lot of work on
spectroscopic investigations of heme axial coordination using a mutated myoglobin with
no axial heme coordination from the polypeptide. Using either cyclopentanethiol to
mimic bis-cysteine coordination, they determined the spectroscopic properties of these
complexes.163 In both cases, the addition of the neutral ligand yields an UV−vis spectrum
with properties similar to those of the spectrum of the ferrous Δ276 DGCR8 protein,
suggesting that, in the ferrous state, DGCR8 is coordinated by neutral axial ligand or
ligands, prospectively through CysH/CysH coordination.

Again the ferrous CO complex have a soret feature at 420nm, which is generally
considered to be the species arising from protonation of proximal thiolate ligand to the
thiol form. However, the histidine ligated heme protein also have a similar spectrum in
their ferrous CO form. Thus, the absence of a Soret band at 450 nm thus strongly
suggests that in its ferrous, CO-bound state the DGCR8 heme iron is not coordinated to
the protein by a thiolate ligand but instead via a neutral thiol or a histidine.
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Figure A2 Uv-vis spectra of DGCR8. Ferric DGCR8 is in red, ferrous form is in green
while the Ferrous-CO complex form is in Blue.

3. Resonance Raman spectroscopic analysis of DGCR8.

A. Preparation of samples for resonance Raman measurements.

The concentration of ferric DGCR8 sample was 85 M in 50 mM Tris (pH=8.0),
500 mM KCl containing 10% glycerol. The 50 μL ferric sample was transferred into an
NMR tube for measurements. The ferrous form of the protein, dissolved in the glycerol
containing buffer, was then generated by first degassing the DGCR8 sample under
oxygen-free nitrogen, before adding a 20-fold molar excess of sodium dithionite and the
redox mediators methyl viologen (MV) and benzyl viologen (BV) to final concentrations
of 0.3 M and 1 M, respectively, these additives being dissolved in the same glycerol
containing buffer. Reduction of the hemoprotein was monitored by electronic absorption
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spectrophotometry in the UV-visible region, noting that full reduction required up to one
hour. The ferrous-CO complex was then prepared by saturation of a sample of DGCR8
with CO prior to the addition of sodium dithionite and the BV and MV mediators (as was
done for the ferrous, CO-free sample). Formation of the DGCR8 ferrous-CO complex
was monitored by observation of the electronic absorption spectrum to ensure complete
formation of the CO complex.
It is noted that a second sample of the ferric enzyme was prepared in glycerol-free
buffer and studied in an effort to resolve an apparent conflict with previous reports
regarding spin state populations (vide infra).36 This second sample was prepared in the
same buffer, but lacking glycerol, by adding 50 µL of the glycerol free buffer (50 mM
Tris (pH=8.0), 500 mM KCl) to 50 µL of the sample in the original (with 10% glycerol)
buffer contained in a centrifugal filter cartridge (10K molecular weight cut-off) and
concentrating the 100 µL resulting solution to 50 µL using a microcentrifuge at 8000 rpm
at 4 °C. This process was repeated 8 times to ensure the buffer was completely
exchanged.
B. Resonance Raman Measurements.

The ferric DGCR8 sample was measured with the 441.6 nm excitation line from
a He-Cd laser (IK Series He−Cd laser, Kimmon Koha CO., Ltd.), while the ferrous
DGCR8 sample was measured with the 415 nm line provided by a Kr+ laser (Coherent
Innova Sabre Ion Laser). The spectra of the Fe(II)-CO adducts were acquired with the
441.6 nm line. The RR spectra of all samples were measured using a Spex 1269
spectrometer equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton
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Instruments, NJ). The slit width was 150 μm, and the laser power was adjusted to ∼30
mW at the laser for the ferric and ferrous samples, while the power of ~1 mW was
maintained for the CO adducts to minimize photo dissociation. All samples were
measured in a spinning NMR tube to avoid local heating and protein degradation. The
spectra were collected using a 180° backscattering geometry, and the laser power was
focused on the sample with a line image using a cylindrical lens. Spectra were calibrated
with data acquired for fenchone and processed with Grams/32 AI software (Galactic
Industries, Salem, NH). Data were collected at 4 (± 2) °C by placing the samples in a
homemade quartz Dewar flask filled with cold water and monitoring during the
measurements using a thermocouple.
C. Results for ferric DGCR8

The high frequency region of ferric DGCR8 sample is presented in Figure A3 (A).
The region includes the oxidation state and spin state markers. As shown in Figure A3
(A), the high frequency spectrum of the DGCR8 sample exhibits the oxidation state
marker mode, ν4, at 1375 cm-1 and the ν3 spin-state marker at 1506 cm-1, confirming the
presence of a ferric 6-coordinate low-spin state, in agreement with results from other
methods used in this work. While there are some small differences (3-6 cm-1) in
frequencies between our results and those reported in the earlier published data from Barr
et al,164 they can be atributed to the one-point spectral calibration method used in the
published work compared to the multipoint calibration used in the present studies; slight
differences in relative intensities of bands between the two works are attributable to the
fact that two different excittaions lines were used (441.6 vs 457.9 nm). A more
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worrisome discrepancy is the fact that a weak 1471 cm-1 band seen in the earlier work
was taken as evidence for a 5-coordinate high spin component. Indeed, in the present
work a band is also observed in Figure A3 near this frequency (1465 cm-1), but is
assigned to an internal mode of glycerol, whose concentration is 10% (volume/volume)
in our sample; it is noted that samples studied in the published report also contained 10%
glycerol. In order to verify the assignment of this 1465cm-1 feature to glycerol, further
experiments were conducted on a DGCR8 sample containing no glycerol. The inset in
Figure A3 (A) shows spectra of the ferric DGCR8 sample containing 10% glycerol buffer
(a), a sample in the same buffer without glycerol (b) and their difference spectrum (c). In
the difference spectrum, all the heme modes were cleanly cancelled out, revealing only
the 1465 cm-1 glycerol band. Thus, we assigned this band to the 10% glycerol present in
the original protein solution, confirming the interpretation that the ferric protein samples
studied here contain an insignificant amount of 5-coordinate HS state. The low frequency
region of the RR spectrum is shown in Figure A4 (A) which is as the supporting
information attached in published article.
D. Results for ferrous DGCR8

In the ferrous state, the high-frequency region (Figure A3 B) exhibited the
oxidation state marker band (4) at 1362 cm-1 and the spin-state marker band (3) at 1495
cm-1, indicating a low-spin 6-coordinated ferrous heme protein. Again, the weak broad
glycerol band near 1465 cm-1 was observed. In the earlier work, a 1470 cm-1 band was
observed and assigned to the ν3 mode of a 5-coordinate HS component, again prompting
the conclusion of a mixture of 5- and 6-coordinate forms of the ferrous protein, as was
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reported in that work for the ferric state.164 While that 1470 cm-1 feature is reasonably
close to the expected glycerol band, the frequency observed is slightly higher than
expected. Considering it not to be a mis-calibrated glycerol band, the authors assigned it
to the ν3 mode of a HS component, also assigning a feature at 1579 cm-1 to the ν2 mode of
that HS component; however, this frequency is unusually high for a HS component.
Acceptance of the 1470 cm-1 feature observed in the earlier work as confirmation of a HS
component suggests that the sample studied there (the frog 278-498) does form a HS
component, while the isoform of interest in this work (human 276-773) does not form a
HS species, under the conditions studied here. The low-frequency rR spectrum of ferrous
DGCR8 is shown in Figure A4 B.
E. Results for ferrous CO complex of DGCR8

As was pointed out above, the appearance of a Soret band near 420 nm for the
ferrous CO adduct of DGCR8 is indicative of a 6-coordinate CO ligated heme bearing a
neutral (e.g., thiol or histidine) trans-axial ligand. Resonance Raman spectra in the region
between 1000-1650 cm-1, provided in Figure A4 (C) of Supporting Information, reveal
the oxidation state marker band (4) at 1373 cm-1 and spin state marker band (3) at 1497
cm-1, consistent with values typically seen for these low spin CO adducts of cytochromes
P450.59, 69 The regions of the RR spectra of the Fe-CO and Fe-13CO adducts of the
DGCR8, wherein the ν(Fe-C) and ν(C-O) stretching modes occur, are shown in Figure
A3 (C). In the lower frequency region a clean difference pattern emerges from a ν(Fe12

C) mode appearing at 496 cm-1, with its 13C counterpart shifting to 490 cm-1. The

corresponding ν(C-O) bands appear at 1963 cm-1 for 12C-O and at 1917 cm-1 for the 13C
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analogue. Finally, a clean difference pattern, with components at 575 and 557 cm-1,
reveal the δ(Fe-C-O) bending mode.
Figure A3 (D) shows the well-established inverse correlation plots for ν(Fe-C) vs
ν(C-O) modes, which are useful for probing the nature of the distal heme pockets and
proximal ligands.57 Thus, the lowest line in the figure includes data for the cytochromes
P450, which possess the strongly electron donating thiolate proximal ligand, leading to
relatively high ν(Fe-S) stretching modes occurring near 350-355 cm-1. Just above this line
lies the correlation plot for NOS enzymes, which possess proximal pocket residues that
provide H-bond donor fragments to the proximal thiolate ligand, weakening the Fe-S
linkage; possessing lower ν(Fe-S) frequencies (337-343 cm-1), these show
correspondingly higher ν(Fe-C) stretching modes. Highest in the figure is the correlation
line for histidine bound Fe-CO complexes. As was discussed above, actual protonation of
the trans-axial thiolate to form a trans thiol-ligated species, as has been suggested for
cytochromes P420,165 would lead to an even weaker Fe-S bond and higher ν(Fe-C)
stretching frequencies, compared to those seen for NOS adducts. Indeed, the points
acquired for the P420 forms of iNOS and for CYP101,127 as well as one for a wellcharacterized CO adduct of a heme model compound bearing a trans-axial thiol,166 lie
near the line corresponding to histidine ligated CO adducts.
It is interesting to note that these rR results described above for the ferrous CO
adduct provide useful insight regarding the coordination status of the ferrous form. Thus,
in the case of the ferrous heme adopting a thiol/thiolate coordination, where it is
reasonably expected that the Fe-thiolate bond is stronger than the Fe-thiol bond, a CO
complex of heme bearing a trans thiolate ligand would likely be formed, for which the
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correlation point would fall near the line corresponding to cytochromes P450. However,
the point determined herein for the CO adduct of DGCR8 clearly lies in the
neighbourhood of these adducts bearing a trans-axial thiol ligand; i.e., near the line
corresponding to histidine-ligated CO adducts. Thus, the rR data obtained here for the
ferrous DGCR8 CO complex supports the conclusion that the ferrous form of this
enzyme possesses a thiol/thiol coordination environment, rather than a thiol/thiolate
formulation.
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Figure A3 A) the high-frequency RR spectra for the ferric DGCR8 aquired with 442 nm
laser lines. (85 M ferric DGCR8, in TRIS pH 8.0, 500mM KCl, 10% glycerol). The
inset shows the ferric DGCR8 in 10% glycerol buffer (a), ferric DGCR8 in same buffer
without glycerol (b) and their difference traces (c); B) The high-frequency RR spectra for
the ferrous DGCR8 acquired with the 415 nm laser line (85 M DGCR8 reduced under
inert atmosphere of N2 with 20 time molar excess of sodium dithionate in the presence of
methyl viologen and benzyl viologen); C) The low-frequency (left-panel) and highfrequency (right panel) RR spectral region of ferrous adducts of DGCR8. The middle
trace in each panel shows 12C16O – 13C16O difference plot in the (Fe-C) and  (C-O) regions
(respectively in the left and right panels); D) The CO-backbonding correlation lines of
P450 cam (L= thiolate), histidine ligated enzymes (L=his) and NOS (L- thiolate).140 Data
points (•) associated with heme- thiol model complex, DGCR8, iNOS P420 and iNOS
P450.166
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Figure A4 A) The low-frequency RR spectra for the ferric DGCR8 acquired with 442nm
laser line. Experimental conditions same as in Figure A1 for the corresponding highfrequency regions; B) the low-frequency RR spectra for the ferrous DGCR8 acquired
with the 415 nm laser line. Experimental condition as in Figure 3C; C) The lowfrequency RR spectra of the carbon monoxide and its 13CO isotopomer complex of
DGCR8 acquired with the 415 nm laser line; D) The high-frequency RR spectra of the
carbon monoxide and its 13CO isotopomer complex of DGCR8 acquired with the 415 nm
laser line.
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